Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Signaling by Receptor Tyrosine Kinases	51/536	1.8774923507675897E-53	1.5639511281894023E-50	0	0	41.664843256890386	5058.406662581158	IRS4;SHB;IGF1R;CRKL;MYC;JAK2;NCK1;PDGFRB;VAV3;HSP90AA1;HGF;GAB1;VAV1;LCK;CDC37;RASA1;SOS1;CRK;SHC1;SRC;PXN;PIK3R3;PIK3R2;PIK3R1;CBL;HIF1A;EGFR;SOCS1;ERBB3;ERBB2;FYN;PLCG1;MAP2K5;MAPK3;LYN;YES1;JUP;TNK2;CAV1;STAT3;PTK6;PTPN11;MAPK14;PTK2;TEC;NEDD4;GRB2;STUB1;PTPN6;FGFR4;FGFR1
Signal Transduction	73/2613	6.262493658904542E-43	2.608328608933742E-40	0	0	18.47885680956547	1795.712117132111	CDKN1A;HSP90AB1;ARAF;IRS4;SHB;GRM1;IGF1R;CRKL;MYC;JAK2;NCK1;PDGFRB;VAV3;HSP90AA1;HGF;GAB1;VAV1;AR;DOK1;ZAP70;KAT2A;LATS2;CCNE1;LCK;CDC37;RASA1;BTK;SOS1;CRK;EPHA2;KHDRBS1;SHC1;SRC;PXN;WAS;PIK3R3;PIK3R2;PIK3R1;CBL;HIF1A;RELA;EGFR;SOCS3;SOCS1;ERBB3;ERBB2;PLCG2;ABL2;FYN;PLCG1;VHL;MAP2K5;MAPK3;LYN;CDKN2B;YES1;JUP;TNK2;CAV1;STAT3;PTK6;PTPN11;MAPK14;PTK2;TEC;SP1;NEDD4;CDK1;GRB2;STUB1;PTPN6;FGFR4;FGFR1
Cytokine Signaling in Immune System	43/776	3.1532497625787126E-34	8.755523507426892E-32	0	0	19.726215265311986	1521.6695849297523	CSF1R;BECN1;CDKN1A;SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;CBL;HIF1A;RELA;CRKL;SOCS3;SOCS1;MYC;PLCG2;BLNK;ABL2;FYN;PLCG1;JAK2;MAP2K6;NCK1;MAPK3;MAP2K3;LYN;HSP90AA1;YES1;HGF;STAT3;PTPN11;MAPK14;VAV1;HCK;TEC;LCK;NEDD4;CDK1;GRB2;PTPN6;SOS1;CRK;CD44
Diseases of Signal Transduction by Growth Factor Receptors and Second Messengers	35/451	1.7575023554876586E-32	3.659998655303049E-30	0	0	25.21967455621302	1844.0330786467512	RB1;CDKN1A;SHC1;SRC;ARAF;PIK3R3;PIK3R2;PIK3R1;CBL;EGFR;ERBB3;MYC;ERBB2;FYN;PLCG1;JAK2;MAPK3;PDGFRB;LYN;HSP90AA1;YES1;HGF;STAT3;GAB1;PTPN11;VAV1;ZAP70;KAT2A;LCK;CDC37;GRB2;PTPN6;FGFR4;SOS1;FGFR1
Interleukin-3, Interleukin-5 and GM-CSF Signaling	19/48	3.187845869780508E-32	5.310951219054326E-30	0	0	160.72754363558963	11656.50433186467	LYN;YES1;SHC1;PIK3R3;PIK3R2;PTPN11;PIK3R1;CBL;VAV1;CRKL;HCK;TEC;BLNK;FYN;GRB2;PTPN6;JAK2;SOS1;CRK
Disease	59/2131	4.938468236670161E-32	6.856240068577075E-30	0	0	12.381721442697053	892.544658292401	RB1;CDKN1A;HSP90AB1;ARAF;IGF1R;CCND2;MYC;BLNK;SKP2;JAK2;NCK1;MAP2K3;PDGFRB;VAV3;HSP90AA1;HGF;GAB1;VAV1;FGR;HCK;ZAP70;KAT2A;CCNE1;LCK;CDC37;BTK;SOS1;CRK;BECN1;SHC1;SRC;WAS;PIK3R3;PIK3R2;PIK3R1;CBL;RELA;EGFR;ERBB3;ERBB2;PLCG2;FYN;PLCG1;VHL;MAP2K6;MAPK3;LYN;YES1;CAV1;STAT3;PTPN11;MAPK14;PTK2;CDK6;SP1;GRB2;PTPN6;FGFR4;FGFR1
Signaling by SCF-KIT	18/43	4.15522755083855E-31	4.897421135985637E-29	0	0	174.5121951219512	12208.13510464052	LYN;YES1;SRC;STAT3;PIK3R3;PIK3R2;PTPN11;PIK3R1;CBL;VAV1;SOCS1;TEC;LCK;FYN;GRB2;PTPN6;JAK2;SOS1
Signaling by Interleukins	34/452	4.703405652807335E-31	4.897421135985637E-29	0	0	24.010004349717267	1676.6630469675836	CSF1R;CDKN1A;SHC1;PIK3R3;PIK3R2;PIK3R1;CBL;HIF1A;RELA;CRKL;SOCS3;SOCS1;MYC;BLNK;FYN;JAK2;MAP2K6;MAPK3;MAP2K3;LYN;HSP90AA1;YES1;HGF;STAT3;PTPN11;MAPK14;VAV1;HCK;TEC;LCK;GRB2;PTPN6;SOS1;CRK
Immune System	57/2150	1.1129746684643479E-29	1.0301198875897798E-27	0	0	11.277891976577518	751.8737284560874	ITK;CDKN1A;HSP90AB1;CBLB;CRKL;MYC;BLNK;SKP2;JAK2;NCK1;MAP2K3;VAV3;HSP90AA1;HGF;VAV1;FGR;HCK;ZAP70;LCK;BTK;LCP2;SOS1;CRK;CD44;CSF1R;BECN1;SHC1;SRC;WAS;PIK3R3;PIK3R2;PIK3R1;CBL;HIF1A;RELA;SOCS3;SOCS1;PLCG2;ABL2;FYN;PLCG1;VHL;MAP2K6;MAPK3;LYN;YES1;JUP;STAT3;PTPN11;MAPK14;PTK2;TEC;NEDD4;CDK1;GRB2;STUB1;PTPN6
Signaling by ERBB2	16/50	1.8569492558011773E-25	1.5468387300823808E-23	0	0	111.29411764705883	6337.720585981471	HSP90AA1;YES1;SHC1;SRC;GAB1;PTK6;PIK3R1;EGFR;ERBB3;CDC37;ERBB2;FYN;GRB2;STUB1;PLCG1;SOS1
Regulation of Signaling by CBL	13/22	2.598449419225722E-25	1.967734878377297E-23	0	0	330.2464878671775	18695.15871081253	LYN;YES1;PIK3R3;PIK3R2;PIK3R1;CBL;VAV1;CRKL;HCK;BLNK;FYN;GRB2;CRK
Signaling by CSF1 (M-CSF) in Myeloid Cells	14/31	5.840370913552958E-25	4.0541908091580125E-23	0	0	190.39808481532148	10624.181339534014	LYN;CSF1R;YES1;SHC1;SRC;STAT3;PTPN11;PIK3R1;CBL;HCK;PLCG2;FYN;GRB2;SOS1
Fcgamma Receptor (FCGR) Dependent Phagocytosis	21/168	8.228708519569616E-24	5.272703228308839E-22	0	0	35.719710669077756	1898.660258609245	LYN;VAV3;HSP90AA1;YES1;HSP90AB1;SRC;WAS;PIK3R2;PIK3R1;PTK2;VAV1;FGR;HCK;BTK;PLCG2;GRB2;FYN;PLCG1;CRK;NCK1;MAPK3
Signaling by KIT in Disease	12/20	1.50078704163666E-23	8.334370704555585E-22	0	0	339.0681818181818	17819.208664627906	LYN;YES1;SRC;LCK;STAT3;PIK3R3;PIK3R2;FYN;GRB2;PIK3R1;JAK2;SOS1
Signaling by Phosphorylated Juxtamembrane, Extracellular and Kinase Domain KIT Mutants	12/20	1.50078704163666E-23	8.334370704555585E-22	0	0	339.0681818181818	17819.208664627906	LYN;YES1;SRC;LCK;STAT3;PIK3R3;PIK3R2;FYN;GRB2;PIK3R1;JAK2;SOS1
Constitutive Signaling by Aberrant PI3K in Cancer	17/83	2.852035095609751E-23	1.4848407716518267E-21	0	0	61.55129609346477	3195.2154496169123	PDGFRB;SRC;HGF;GAB1;PIK3R3;PIK3R2;PTPN11;PIK3R1;VAV1;EGFR;ERBB3;LCK;ERBB2;FYN;GRB2;FGFR4;FGFR1
Downstream Signal Transduction	13/29	3.446854619273042E-23	1.6889587634437907E-21	0	0	185.69827586206895	9604.6853008895	PDGFRB;SRC;STAT3;PIK3R2;PTPN11;PIK3R1;CRKL;RASA1;GRB2;PLCG1;SOS1;CRK;NCK1
PI3K AKT Signaling in Cancer	18/110	1.0498884313273566E-22	4.8586503516427114E-21	0	0	47.26193001060445	2391.840645988547	PDGFRB;CDKN1A;SRC;HGF;GAB1;PIK3R3;PIK3R2;PTPN11;PIK3R1;VAV1;EGFR;ERBB3;LCK;ERBB2;GRB2;FYN;FGFR4;FGFR1
PI5P, PP2A and IER3 Regulate PI3K AKT Signaling	18/111	1.2482149579698894E-22	5.47243715783641E-21	0	0	46.751376868607394	2357.9130579911016	PDGFRB;SRC;HGF;GAB1;PIK3R3;PIK3R2;PTPN11;PIK3R1;VAV1;EGFR;ERBB3;LCK;ERBB2;GRB2;FYN;FGFR4;FGFR1;MAPK3
Negative Regulation of the PI3K AKT Network	18/118	4.0003601509356212E-22	1.6661500028646863E-20	0	0	43.46341463414634	2141.463634004971	PDGFRB;SRC;HGF;GAB1;PIK3R3;PIK3R2;PTPN11;PIK3R1;VAV1;EGFR;ERBB3;LCK;ERBB2;GRB2;FYN;FGFR4;FGFR1;MAPK3
VEGFA-VEGFR2 Pathway	17/99	7.25414436966377E-22	2.877477266633295E-20	0	0	49.50132236262122	2409.491672001032	VAV3;HSP90AA1;JUP;SRC;CAV1;PXN;PIK3R2;PIK3R1;SHB;MAPK14;PTK2;VAV1;RASA1;FYN;PLCG1;CRK;NCK1
Signaling by VEGF	17/108	3.4942353278119125E-21	1.3230445582124198E-19	0	0	44.585330332318286	2100.110500773063	VAV3;HSP90AA1;JUP;SRC;CAV1;PXN;PIK3R2;PIK3R1;SHB;MAPK14;PTK2;VAV1;RASA1;FYN;PLCG1;CRK;NCK1
DAP12 Signaling	12/29	5.961925971069591E-21	2.1592540582178129E-19	0	0	159.48930481283423	7427.2404302005625	VAV3;SHC1;LCK;PLCG2;BTK;PIK3R2;FYN;GRB2;LCP2;PIK3R1;PLCG1;SOS1
Signaling by Non-Receptor Tyrosine Kinases	14/55	8.7088755476134E-21	2.9017973324647853E-19	0	0	78.85025524673851	3642.0888954713187	KHDRBS1;PXN;STAT3;PTK6;CBL;HIF1A;EGFR;DOK1;SOCS3;ERBB3;CCNE1;RASA1;ERBB2;CRK
Signaling by PTK6	14/55	8.7088755476134E-21	2.9017973324647853E-19	0	0	78.85025524673851	3642.0888954713187	KHDRBS1;PXN;STAT3;PTK6;CBL;HIF1A;EGFR;DOK1;SOCS3;ERBB3;CCNE1;RASA1;ERBB2;CRK
Constitutive Signaling by EGFRvIII	10/15	1.807033125385265E-20	5.5750318275775025E-19	0	0	442.1111111111111	20098.377971232938	HSP90AA1;SHC1;CDC37;GAB1;GRB2;PIK3R1;PLCG1;CBL;SOS1;EGFR
Signaling by EGFRvIII in Cancer	10/15	1.807033125385265E-20	5.5750318275775025E-19	0	0	442.1111111111111	20098.377971232938	HSP90AA1;SHC1;CDC37;GAB1;GRB2;PIK3R1;PLCG1;CBL;SOS1;EGFR
Regulation of KIT Signaling	10/16	4.7992314832699284E-20	1.3785378708840865E-18	0	0	368.4074074074074	16387.95735492846	LYN;YES1;SOCS1;SRC;LCK;FYN;GRB2;PTPN6;CBL;SOS1
Signaling by ERBB2 ECD Mutants	10/16	4.7992314832699284E-20	1.3785378708840865E-18	0	0	368.4074074074074	16387.95735492846	HSP90AA1;SHC1;CDC37;ERBB2;GAB1;GRB2;PIK3R1;PLCG1;SOS1;EGFR
Innate Immune System	36/1149	7.125780037157327E-20	1.978591590317351E-18	0	0	9.494777628032345	418.60559143302504	ITK;HSP90AB1;SHC1;SRC;WAS;PIK3R2;PIK3R1;RELA;SOCS1;PLCG2;FYN;PLCG1;MAP2K6;NCK1;MAPK3;MAP2K3;LYN;VAV3;HSP90AA1;YES1;JUP;PTPN11;MAPK14;PTK2;VAV1;FGR;HCK;TEC;LCK;BTK;GRB2;LCP2;PTPN6;SOS1;CRK;CD44
GPVI-mediated Activation Cascade	12/35	9.355994411619025E-20	2.514046240283435E-18	0	0	117.84782608695652	5163.583179619164	LYN;VAV3;LCK;PLCG2;PIK3R3;PIK3R2;FYN;PTPN11;LCP2;PTPN6;PIK3R1;VAV1
Platelet Activation, Signaling and Aggregation	21/262	1.0510676074720384E-19	2.73606036570065E-18	0	0	21.683859446399495	947.5697035395407	LYN;VAV3;SHC1;SRC;HGF;PIK3R3;PIK3R2;PTPN11;PIK3R1;MAPK14;PTK2;VAV1;LCK;PLCG2;GRB2;LCP2;FYN;PTPN6;SOS1;CRK;MAPK3
Signaling by ERBB2 KD Mutants	11/25	1.1641078916199254E-19	2.8520643344688173E-18	0	0	175.5585874799358	7653.856131712588	HSP90AA1;ERBB3;SHC1;CDC37;ERBB2;GAB1;GRB2;PIK3R1;PLCG1;SOS1;EGFR
Signaling by Erythropoietin	11/25	1.1641078916199254E-19	2.8520643344688173E-18	0	0	175.5585874799358	7653.856131712588	LYN;SHC1;PLCG2;GAB1;GRB2;PIK3R1;PLCG1;JAK2;SOS1;VAV1;CRKL
Signaling by ERBB2 in Cancer	11/26	2.009594785989382E-19	4.782835590654729E-18	0	0	163.84644194756555	7053.783265002127	HSP90AA1;ERBB3;SHC1;CDC37;ERBB2;GAB1;GRB2;PIK3R1;PLCG1;SOS1;EGFR
MAPK1 MAPK3 Signaling	21/271	2.1229276428096142E-19	4.912218684612246E-18	0	0	20.89367088607595	898.3509733340574	PDGFRB;SHC1;SRC;HGF;ARAF;PIK3R2;PTPN11;PIK3R1;PTK2;EGFR;ERBB3;RASA1;ERBB2;CDK1;GRB2;FYN;FGFR4;JAK2;SOS1;FGFR1;MAPK3
MAPK Family Signaling Cascades	22/314	2.3729810712032996E-19	5.342414141384725E-18	0	0	18.939936775553214	812.2386159933764	PDGFRB;SHC1;SRC;HGF;ARAF;PIK3R2;PTPN11;PIK3R1;PTK2;EGFR;ERBB3;MYC;RASA1;ERBB2;CDK1;GRB2;FYN;FGFR4;JAK2;SOS1;FGFR1;MAPK3
Intracellular Signaling by Second Messengers	22/321	3.817224402412608E-19	8.367757703183428E-18	0	0	18.489923677214648	784.1501415346719	PDGFRB;CDKN1A;SRC;HGF;GAB1;PIK3R3;PIK3R2;PTPN11;PIK3R1;VAV1;EGFR;ERBB3;LCK;NEDD4;ERBB2;GRB2;FYN;STUB1;PLCG1;FGFR4;FGFR1;MAPK3
PIP3 Activates AKT Signaling	21/281	4.502359649317663E-19	9.616578430465674E-18	0	0	20.079844206426486	848.2632826078599	PDGFRB;CDKN1A;SRC;HGF;GAB1;PIK3R3;PIK3R2;PTPN11;PIK3R1;VAV1;EGFR;ERBB3;LCK;NEDD4;ERBB2;GRB2;FYN;STUB1;FGFR4;FGFR1;MAPK3
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	10/19	5.469097422410812E-19	1.1111605250898064E-17	0	0	245.5679012345679	10326.131025145649	HSP90AA1;SHC1;CDC37;GAB1;GRB2;PIK3R1;PLCG1;CBL;SOS1;EGFR
Signaling by Ligand-Responsive EGFR Variants in Cancer	10/19	5.469097422410812E-19	1.1111605250898064E-17	0	0	245.5679012345679	10326.131025145649	HSP90AA1;SHC1;CDC37;GAB1;GRB2;PIK3R1;PLCG1;CBL;SOS1;EGFR
Leishmania Infection	20/245	5.950477085470131E-19	1.1496855409866973E-17	0	0	21.86111111111111	917.4156362417777	LYN;VAV3;YES1;HSP90AB1;SRC;WAS;MAPK14;PTK2;VAV1;RELA;FGR;HCK;BTK;PLCG2;GRB2;FYN;PLCG1;CRK;NCK1;MAPK3
Parasitic Infection Pathways	20/245	5.950477085470131E-19	1.1496855409866973E-17	0	0	21.86111111111111	917.4156362417777	LYN;VAV3;YES1;HSP90AB1;SRC;WAS;MAPK14;PTK2;VAV1;RELA;FGR;HCK;BTK;PLCG2;GRB2;FYN;PLCG1;CRK;NCK1;MAPK3
Infectious Disease	37/1311	6.072768763915328E-19	1.1496855409866973E-17	0	0	8.586404525180034	360.159331991468	RB1;BECN1;HSP90AB1;SRC;WAS;CBL;RELA;EGFR;IGF1R;PLCG2;BLNK;FYN;PLCG1;VHL;JAK2;MAP2K6;NCK1;MAPK3;MAP2K3;LYN;VAV3;HSP90AA1;YES1;CAV1;PTPN11;MAPK14;PTK2;VAV1;FGR;HCK;SP1;LCK;BTK;GRB2;PTPN6;SOS1;CRK
Adaptive Immune System	31/854	8.206084950933431E-19	1.5190375031394554E-17	0	0	10.414126472608167	433.6883907617444	ITK;BECN1;SRC;WAS;PIK3R3;CBLB;PIK3R2;PIK3R1;RELA;SOCS3;SOCS1;PLCG2;BLNK;FYN;PLCG1;VHL;SKP2;NCK1;LYN;YES1;PTPN11;VAV1;ZAP70;LCK;NEDD4;BTK;GRB2;LCP2;STUB1;PTPN6;SOS1
Axon Guidance	26/541	1.0337869042051038E-18	1.8720532417453292E-17	0	0	13.225137759118342	547.6966373385598	HSP90AB1;SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;EGFR;ERBB2;ABL2;FYN;PLCG1;NCK1;MAPK3;LYN;VAV3;HSP90AA1;YES1;GAB1;PTPN11;PTK2;DOK1;RASA1;GRB2;SOS1;EPHA2;FGFR1
Signaling by PDGF	13/58	1.4256685005112919E-18	2.52676991686363E-17	0	0	65.92975734355045	2709.178392331048	PDGFRB;SRC;STAT3;PIK3R2;PTPN11;PIK3R1;CRKL;RASA1;GRB2;PLCG1;SOS1;CRK;NCK1
DAP12 Interactions	12/45	3.096295279619695E-18	5.373362433173346E-17	0	0	82.09504132231405	3309.7703954209737	VAV3;SHC1;LCK;PLCG2;BTK;PIK3R2;FYN;GRB2;LCP2;PIK3R1;PLCG1;SOS1
Nervous System Development	26/567	3.2774292187059287E-18	5.571629671800079E-17	0	0	12.572663236249188	506.1687877193635	HSP90AB1;SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;EGFR;ERBB2;ABL2;FYN;PLCG1;NCK1;MAPK3;LYN;VAV3;HSP90AA1;YES1;GAB1;PTPN11;PTK2;DOK1;RASA1;GRB2;SOS1;EPHA2;FGFR1
Signaling by NTRKs	16/134	5.496554147721465E-18	8.938461229922625E-17	0	0	31.93220338983051	1269.0627287929747	SHC1;SRC;STAT3;GAB1;PIK3R2;PTPN11;PIK3R1;MAPK14;CRKL;GRB2;FYN;PLCG1;SOS1;CRK;MAP2K5;MAPK3
Cyclin D Associated Events in G1	12/47	5.579831740167785E-18	8.938461229922625E-17	0	0	77.3961038961039	3074.7438922554334	RB1;LYN;CDKN1A;CDKN2B;CCND2;CDKN2C;CDK6;SRC;CCNE1;PTK6;JAK2;SKP2
G1 Phase	12/47	5.579831740167785E-18	8.938461229922625E-17	0	0	77.3961038961039	3074.7438922554334	RB1;LYN;CDKN1A;CDKN2B;CCND2;CDKN2C;CDK6;SRC;CCNE1;PTK6;JAK2;SKP2
Signaling by EGFR in Cancer	10/25	1.8884280988059418E-17	2.9680388798214143E-16	0	0	147.2962962962963	5672.115500937475	HSP90AA1;SHC1;CDC37;GAB1;GRB2;PIK3R1;PLCG1;CBL;SOS1;EGFR
RAF MAP Kinase Cascade	19/265	5.572679427401062E-17	8.596374005602009E-16	0	0	18.740640369366655	701.3885294859073	PDGFRB;SHC1;SRC;HGF;ARAF;PIK3R2;PIK3R1;PTK2;EGFR;ERBB3;RASA1;ERBB2;GRB2;FYN;FGFR4;JAK2;SOS1;FGFR1;MAPK3
Hemostasis	27/707	6.60396357392292E-17	1.0002003012868713E-15	0	0	10.454069298952458	389.4796970901565	SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;PLCG2;FYN;PLCG1;JAK2;MAPK3;LYN;VAV3;YES1;HGF;CAV1;PTPN11;MAPK14;PTK2;VAV1;FGR;LCK;GRB2;LCP2;PTPN6;SOS1;CRK;CD44
RET Signaling	11/41	7.730432447430852E-17	1.1297281102999824E-15	0	0	81.86142322097378	3036.959075933281	DOK1;SHC1;SRC;GAB1;PIK3R3;PIK3R2;PTPN11;GRB2;PIK3R1;PLCG1;SOS1
Signaling by FGFR4	11/41	7.730432447430852E-17	1.1297281102999824E-15	0	0	81.86142322097378	3036.959075933281	SHC1;SRC;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;CBL;FGFR4;SOS1;MAPK3
Signaling by MET	13/79	1.0952223941605483E-16	1.5729659557512702E-15	0	0	44.90456287008011	1650.2608289650645	SHC1;SRC;HGF;STAT3;GAB1;PTPN11;PIK3R1;CBL;PTK2;CRKL;GRB2;SOS1;CRK
Fc Epsilon Receptor (FCERI) Signaling	17/197	1.2506626645507737E-16	1.7657661009674484E-15	0	0	22.43908969210174	821.6675841246729	LYN;VAV3;ITK;SHC1;PIK3R2;PIK3R1;VAV1;RELA;TEC;BTK;PLCG2;GRB2;LCP2;FYN;PLCG1;SOS1;MAPK3
PECAM1 Interactions	8/12	1.4282873546391727E-16	1.9829389440240513E-15	0	0	432.5217391304348	15780.506091883326	LYN;YES1;LCK;SRC;FYN;PTPN11;PTPN6;PLCG1
Developmental Biology	35/1385	2.2893270797578194E-16	3.126245012193875E-15	0	0	7.398860398860399	266.4559258082878	CDKN1A;HSP90AB1;SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;RELA;EGFR;MYC;ERBB2;ABL2;FYN;PLCG1;TEAD2;MAP2K6;NCK1;MAPK3;LYN;VAV3;HSP90AA1;YES1;JUP;STAT3;GAB1;PTPN11;MAPK14;PTK2;DOK1;KAT2A;RASA1;GRB2;SOS1;EPHA2;FGFR1
Signaling by Rho GTPases, Miro GTPases and RHOBTB3	26/688	3.5643663075897333E-16	4.7888986035842704E-15	0	0	10.210418878092595	363.1884304803923	HSP90AB1;SRC;WAS;PIK3R3;PIK3R2;PIK3R1;ABL2;VHL;NCK1;MAPK3;VAV3;HSP90AA1;JUP;CAV1;MAPK14;PTK2;VAV1;AR;ZAP70;CCNE1;LCK;CDC37;BTK;GRB2;SOS1;EPHA2
FCGR3A-mediated Phagocytosis	15/142	4.179650153610609E-16	5.356382427627135E-15	0	0	27.47522000926355	972.9286957839226	LYN;VAV3;YES1;SRC;WAS;PTK2;VAV1;FGR;HCK;BTK;GRB2;FYN;CRK;NCK1;MAPK3
Leishmania Phagocytosis	15/142	4.179650153610609E-16	5.356382427627135E-15	0	0	27.47522000926355	972.9286957839226	LYN;VAV3;YES1;SRC;WAS;PTK2;VAV1;FGR;HCK;BTK;GRB2;FYN;CRK;NCK1;MAPK3
Parasite Infection	15/142	4.179650153610609E-16	5.356382427627135E-15	0	0	27.47522000926355	972.9286957839226	LYN;VAV3;YES1;SRC;WAS;PTK2;VAV1;FGR;HCK;BTK;GRB2;FYN;CRK;NCK1;MAPK3
Signaling by ERBB2 TMD JMD Mutants	9/22	6.365453909033976E-16	8.03397440337167E-15	0	0	151.2958579881657	5293.914079536796	HSP90AA1;ERBB3;SHC1;CDC37;ERBB2;GRB2;PLCG1;SOS1;EGFR
CD28 Co-Stimulation	10/35	1.0180884444157728E-15	1.2657726480572221E-14	0	0	88.33333333333333	3049.3417146658417	LYN;YES1;SRC;LCK;PIK3R3;PIK3R2;FYN;GRB2;PIK3R1;VAV1
Signaling by FGFR1	11/52	1.4130175563175049E-15	1.7309465064889435E-14	0	0	59.865442587010136	2046.9820037882366	SHC1;SRC;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1;CBL;MAPK3;FGFR1
IGF1R Signaling Cascade	11/53	1.7758240571717883E-15	2.1132306280344283E-14	0	0	58.43713215623328	1984.788665973274	SHC1;IRS4;GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;SOS1;FGFR4;IGF1R;FGFR1
Signaling by EGFR	11/53	1.7758240571717883E-15	2.1132306280344283E-14	0	0	58.43713215623328	1984.788665973274	SHC1;SRC;PXN;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1;CBL;EGFR
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	11/54	2.2210120696356616E-15	2.6057789493049383E-14	0	0	57.075254768748366	1925.765521805209	SHC1;IRS4;GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;SOS1;FGFR4;IGF1R;FGFR1
Signaling by NTRK2 (TRKB)	9/25	2.5824983039216764E-15	2.987807065509384E-14	0	0	122.90934065934066	4128.527103960849	SHC1;SRC;GAB1;FYN;PTPN11;GRB2;PIK3R1;PLCG1;SOS1
Costimulation by the CD28 Family	12/78	4.088241578941579E-15	4.665075664737446E-14	0	0	40.97933884297521	1357.6726016146583	LYN;YES1;LCK;SRC;PIK3R3;PIK3R2;FYN;PTPN11;GRB2;PTPN6;PIK3R1;VAV1
Signaling by FGFR3	10/40	4.605702129266222E-15	5.184526856322653E-14	0	0	73.5925925925926	2429.4004916689582	SHC1;SRC;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;CBL;SOS1;MAPK3
Mitotic G1 Phase and G1 S Transition	14/139	8.355773909428813E-15	9.280479555405602E-14	0	0	25.753488372093024	834.8205363824706	RB1;LYN;CDKN1A;CDKN2B;CDKN2C;SRC;PTK6;CCND2;CDK6;CCNE1;MYC;CDK1;SKP2;JAK2
Interleukin-2 Family Signaling	10/44	1.326271534366037E-14	1.4536634054301433E-13	0	0	64.92156862745098	2074.492095580809	SHC1;LCK;STAT3;PIK3R3;PIK3R2;GRB2;PTPN6;PIK3R1;JAK2;SOS1
Cellular Responses to Stimuli	27/887	1.732829257677225E-14	1.8449984475665279E-13	0	0	8.188595093978973	259.46739290272495	RB1;CDKN1A;HSP90AB1;SHC1;PIK3R2;HIF1A;RELA;MYC;FYN;VHL;SKP2;MAP2K6;MAPK3;MAP2K3;HSP90AA1;CDKN2B;CDKN2C;HSPA4;STAT3;PTK6;MAPK14;PTK2;AR;CDK6;CCNE1;SP1;MDM4
Signaling by NTRK1 (TRKA)	13/115	1.7521389384094052E-14	1.8449984475665279E-13	0	0	29.003155285102547	918.6852110568726	SHC1;SRC;STAT3;PIK3R2;PIK3R1;MAPK14;CRKL;GRB2;PLCG1;SOS1;CRK;MAP2K5;MAPK3
Signaling by ALK	9/30	1.771907272572896E-14	1.8449984475665279E-13	0	0	93.62166405023548	2964.448988847377	SHC1;SRC;MYC;STAT3;PIK3R2;PTPN6;PIK3R1;PLCG1;HIF1A
Signaling by CSF3 (G-CSF)	9/30	1.771907272572896E-14	1.8449984475665279E-13	0	0	93.62166405023548	2964.448988847377	LYN;SOCS3;HCK;SOCS1;SHC1;STAT3;PTPN11;GRB2;JAK2
Signaling by Rho GTPases	24/672	2.0671617694746632E-14	2.1258589555214747E-13	0	0	9.382066276803119	295.6290468740321	VAV3;HSP90AA1;HSP90AB1;JUP;SRC;CAV1;WAS;PIK3R3;PIK3R2;PIK3R1;MAPK14;PTK2;VAV1;AR;ZAP70;LCK;CDC37;BTK;ABL2;GRB2;SOS1;EPHA2;NCK1;MAPK3
Signaling by FGFR	12/91	2.8166828772506867E-14	2.861337605792466E-13	0	0	34.21346375143843	1067.4816712204502	SHC1;SRC;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1;CBL;FGFR4;MAPK3;FGFR1
IRS-related Events Triggered by IGF1R	10/52	8.183434642088804E-14	8.213013321518041E-13	0	0	52.53439153439153	1583.0755234444878	IRS4;GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;SOS1;FGFR4;IGF1R;FGFR1
Extra-nuclear Estrogen Signaling	11/75	1.0430178612954102E-13	1.0343260457846151E-12	0	0	38.30688202247191	1145.0497007727627	HSP90AA1;SHC1;SRC;CAV1;PIK3R3;PIK3R2;PIK3R1;EGFR;PTK2;IGF1R;MAPK3
Cellular Senescence	14/167	1.095008512687509E-13	1.0731083424337589E-12	0	0	21.01063991488068	627.0172508230692	RB1;MAP2K3;CDKN1A;CDKN2B;CDKN2C;STAT3;MAPK14;RELA;CDK6;CCNE1;SP1;MDM4;MAP2K6;MAPK3
Insulin Receptor Signalling Cascade	10/54	1.227792687113897E-13	1.1892457074021818E-12	0	0	50.14141414141414	1490.6234252459578	SHC1;GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;SOS1;FGFR4;MAPK3;FGFR1
FLT3 Signaling	9/38	1.953764616321579E-13	1.8706734774665235E-12	0	0	67.76771504357711	1983.1441208158462	HCK;LCK;ABL2;FYN;PTPN11;GRB2;PIK3R1;CBL;SOS1
Erythropoietin Activates RAS	7/14	2.103653482566767E-13	1.991299262475133E-12	0	0	213.90322580645162	6243.8203211568825	LYN;SHC1;GRB2;JAK2;SOS1;VAV1;CRKL
FCERI Mediated Ca+2 Mobilization	12/110	2.906097409182745E-13	2.719976563875536E-12	0	0	27.553803339517625	795.3899958975134	LYN;VAV3;ITK;TEC;SHC1;BTK;PLCG2;GRB2;LCP2;PLCG1;SOS1;VAV1
Downstream Signaling of Activated FGFR4	8/27	6.025445984612907E-13	5.51560055514566E-12	0	0	90.98855835240275	2560.2009979330746	SHC1;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;FGFR4;SOS1
Interleukin Receptor SHC Signaling	8/27	6.025445984612907E-13	5.51560055514566E-12	0	0	90.98855835240275	2560.2009979330746	SHC1;PIK3R3;PIK3R2;GRB2;PTPN6;PIK3R1;JAK2;SOS1
Cellular Responses to Stress	24/787	6.314435972845297E-13	5.717309962369709E-12	0	0	7.92039732358419	222.49004188331168	RB1;MAP2K3;CDKN1A;HSP90AA1;CDKN2B;HSP90AB1;CDKN2C;SHC1;HSPA4;STAT3;PTK6;MAPK14;HIF1A;RELA;AR;CDK6;CCNE1;SP1;MYC;MDM4;VHL;SKP2;MAP2K6;MAPK3
Cell Surface Interactions at the Vascular Wall	15/233	6.626249024766002E-13	5.935124126483957E-12	0	0	15.932541824069077	446.78937672446654	LYN;YES1;SHC1;SRC;CAV1;PIK3R2;PTPN11;PIK3R1;LCK;GRB2;FYN;PTPN6;PLCG1;SOS1;CD44
ESR-mediated Signaling	14/192	7.51953864480849E-13	6.663591160771779E-12	0	0	18.036843480533054	503.51835195815767	HSP90AA1;HSP90AB1;SHC1;SRC;CAV1;PIK3R3;PIK3R2;PIK3R1;PTK2;EGFR;IGF1R;SP1;MYC;MAPK3
RHO GTPase Cycle	19/450	8.341585999517604E-13	7.3142538290507E-12	0	0	10.59582939474664	294.6949457890564	VAV3;HSP90AA1;HSP90AB1;JUP;SRC;CAV1;WAS;PIK3R3;PIK3R2;PIK3R1;VAV1;ZAP70;LCK;CDC37;ABL2;GRB2;SOS1;EPHA2;NCK1
GAB1 Signalosome	7/17	1.1776305932533702E-12	1.0218398793542265E-11	0	0	149.70967741935485	4112.153059869295	SRC;PXN;GAB1;PTPN11;GRB2;PIK3R1;EGFR
Signaling by ALK Fusions and Activated Point Mutants	11/93	1.2059718300720768E-12	1.0250760555612653E-11	0	0	29.87092354069608	819.7697210889528	RB1;ZAP70;CDKN1A;SHC1;STAT3;PIK3R2;GRB2;PTPN6;PIK3R1;PLCG1;MAPK3
Signaling by ALK in Cancer	11/93	1.2059718300720768E-12	1.0250760555612653E-11	0	0	29.87092354069608	819.7697210889528	RB1;ZAP70;CDKN1A;SHC1;STAT3;PIK3R2;GRB2;PTPN6;PIK3R1;PLCG1;MAPK3
Antigen Activates B Cell Receptor (BCR) Leading to Generation of Second Messengers	11/95	1.5320632521895938E-12	1.2890996859332642E-11	0	0	29.156768325307652	793.1925561175326	LYN;BLNK;BTK;PLCG2;FYN;GRB2;PTPN6;PIK3R1;SOS1;VAV1;NCK1
Downstream Signaling of Activated FGFR1	8/31	2.106313405693771E-12	1.754559066942911E-11	0	0	75.14933837429112	2020.4712660868786	SHC1;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1;FGFR1
Signaling by FGFR2	10/75	3.9021184368312554E-12	3.21828183948558E-11	0	0	33.9059829059829	890.6932695310954	SHC1;SRC;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1;CBL;MAPK3
Signalling to ERKs	8/34	4.7886230166494255E-12	3.910708796930364E-11	0	0	66.46822742474916	1732.479606254108	SHC1;SRC;GRB2;MAPK14;SOS1;CRK;CRKL;MAPK3
Constitutive Signaling by Overexpressed ERBB2	6/11	6.074487967833078E-12	4.8654312280816867E-11	0	0	253.9787234042553	6559.489038498821	HSP90AA1;SHC1;CDC37;ERBB2;GRB2;SOS1
Signaling by FGFR4 in Disease	6/11	6.074487967833078E-12	4.8654312280816867E-11	0	0	253.9787234042553	6559.489038498821	GAB1;GRB2;PIK3R1;PLCG1;FGFR4;SOS1
Generic Transcription Pathway	28/1230	6.1839203718560105E-12	4.905910161672435E-11	0	0	6.049454612682566	156.13078958255664	RB1;CSF1R;CDKN1A;SRC;RELA;EGFR;SOCS3;CCND2;MYC;ERBB2;SKP2;TEAD2;MAP2K6;MAPK3;CDKN2B;YES1;CAV1;PTPN11;MAPK14;AR;KAT2A;CDK6;CCNE1;SP1;CDK1;MDM4;STUB1;TP73
Signaling by Insulin Receptor	10/82	9.785475361000104E-12	7.689906580861402E-11	0	0	30.598765432098766	775.6824347849118	SHC1;GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;SOS1;FGFR4;MAPK3;FGFR1
TCR Signaling	11/113	1.0596777082173211E-11	8.249640476121762E-11	0	0	23.989645296320777	606.2296407962513	ITK;ZAP70;LCK;PLCG2;WAS;PIK3R2;LCP2;PIK3R1;PLCG1;RELA;NCK1
Signaling by LTK	6/12	1.2100229834924697E-11	9.332862456011364E-11	0	0	211.63829787234042	5320.120499263678	SHC1;TNK2;GRB2;PIK3R2;PIK3R1;SOS1
Growth Hormone Receptor Signaling	7/24	2.0369288050871164E-11	1.5566621051720808E-10	0	0	88.03352308665401	2167.120607254655	LYN;SOCS3;SOCS1;STAT3;PTPN6;JAK2;MAPK3
Cell-Cell Communication	12/157	2.075245424036942E-11	1.5715267620207023E-10	0	0	18.578369905956112	456.99736798601646	JUP;SP1;SRC;PXN;PIK3R2;GRB2;FYN;PTPN11;PTPN6;PIK3R1;PTK2;NCK1
Generation of Second Messenger Molecules	8/41	2.448876154589047E-11	1.8377602133087174E-10	0	0	52.35046113306983	1279.068703594446	ITK;ZAP70;LCK;WAS;PLCG2;LCP2;PLCG1;NCK1
Downstream Signaling of Activated FGFR3	7/25	2.8175782545196892E-11	2.0955738267990188E-10	0	0	83.13859020310633	2019.6490479869533	SHC1;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1
Signaling by the B Cell Receptor (BCR)	12/162	3.002676773185505E-11	2.2134776566933856E-10	0	0	17.954545454545453	435.01945865333914	LYN;BTK;PLCG2;BLNK;GRB2;FYN;PTPN6;PIK3R1;SOS1;VAV1;RELA;NCK1
SARS-CoV Infections	18/498	4.64864033186588E-11	3.396769646003752E-10	0	0	8.88109756097561	211.29784089928182	RB1;BECN1;HSP90AA1;HSP90AB1;CAV1;PTPN11;VAV1;RELA;SP1;BTK;PLCG2;BLNK;GRB2;PTPN6;VHL;JAK2;SOS1;NCK1
RNA Polymerase II Transcription	28/1360	6.571963368031417E-11	4.76038737875667E-10	0	0	5.421087754421087	127.1007818907291	RB1;CSF1R;CDKN1A;SRC;RELA;EGFR;SOCS3;CCND2;MYC;ERBB2;SKP2;TEAD2;MAP2K6;MAPK3;CDKN2B;YES1;CAV1;PTPN11;MAPK14;AR;KAT2A;CDK6;CCNE1;SP1;CDK1;MDM4;STUB1;TP73
Signaling by Nuclear Receptors	14/270	7.480522324052171E-11	5.37178887580643E-10	0	0	12.491642441860465	291.25680160907893	HSP90AA1;HSP90AB1;SHC1;SRC;CAV1;PIK3R3;PIK3R2;PIK3R1;PTK2;EGFR;IGF1R;SP1;MYC;MAPK3
IRS-mediated Signalling	8/48	9.398156584218372E-11	6.691166183464875E-10	0	0	43.17391304347826	996.7959566837154	GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;FGFR4;SOS1;FGFR1
PI3K Events in ERBB2 Signaling	6/16	1.0319401695537806E-10	7.284797976595757E-10	0	0	126.95744680851064	2919.311614912519	ERBB3;ERBB2;GAB1;GRB2;PIK3R1;EGFR
Downstream Signaling of Activated FGFR2	7/30	1.1692252677215784E-10	8.184576874051049E-10	0	0	65.04862085086489	1487.6300567258356	SHC1;GAB1;PTPN11;GRB2;PIK3R1;PLCG1;SOS1
Interferon Signaling	14/280	1.2102026984932975E-10	8.400823732040973E-10	0	0	12.015911872705018	274.3841053960485	BECN1;STAT3;PTPN11;SOCS3;SOCS1;NEDD4;CDK1;PTPN6;PLCG1;JAK2;CD44;MAP2K6;NCK1;MAPK3
Regulation of Actin Dynamics for Phagocytic Cup Formation	11/143	1.3919240866048413E-10	9.582419538362254E-10	0	0	18.50936329588015	420.07303377719785	VAV3;HSP90AA1;HSP90AB1;BTK;WAS;GRB2;CRK;PTK2;VAV1;NCK1;MAPK3
Signaling by NTRK3 (TRKC)	6/17	1.588407279315142E-10	1.0845436587455027E-9	0	0	115.4100580270793	2604.0108877049797	SHC1;SRC;GRB2;PIK3R1;PLCG1;SOS1
FCERI Mediated MAPK Activation	10/111	2.0931253056653934E-10	1.417539333023799E-9	0	0	21.78107810781078	485.43908324569253	LYN;VAV3;SHC1;PLCG2;GRB2;LCP2;PLCG1;SOS1;VAV1;MAPK3
Interleukin-4 and Interleukin-13 Signaling	10/112	2.2889211611090158E-10	1.5376381670998469E-9	0	0	21.56644880174292	478.7270773793685	SOCS3;CDKN1A;HSP90AA1;SOCS1;MYC;HGF;STAT3;PIK3R1;JAK2;HIF1A
Tie2 Signaling	6/18	2.373034023799583E-10	1.5813898734600422E-9	0	0	105.7872340425532	2344.4229997513735	SHC1;PIK3R2;PTPN11;GRB2;PIK3R1;SOS1
Oncogene Induced Senescence	7/35	3.7842821207002547E-10	2.501830957574057E-9	0	0	53.41935483870968	1158.9326214557811	RB1;CDKN2B;CDKN2C;CDK6;SP1;MDM4;MAPK3
Signaling by ERBB4	8/58	4.582416898182106E-10	3.0056325009336177E-9	0	0	34.52173913043478	742.3425106520441	ERBB3;SHC1;SRC;NEDD4;GRB2;PIK3R1;SOS1;EGFR
CTLA4 Inhibitory Signaling	6/21	6.853233235378736E-10	4.451008712409175E-9	0	0	84.61702127659575	1785.5147986513823	LYN;YES1;SRC;LCK;PTPN11;FYN
Gene Expression (Transcription)	29/1615	6.950342491819E-10	4.451008712409175E-9	0	0	4.716498232776229	99.45708118756107	RB1;CSF1R;CDKN1A;SRC;RELA;EGFR;SOCS3;CCND2;MYC;ERBB2;SKP2;TEAD2;MAP2K6;MAPK3;HSP90AA1;CDKN2B;YES1;CAV1;PTPN11;MAPK14;AR;KAT2A;CDK6;CCNE1;SP1;CDK1;MDM4;STUB1;TP73
MET Receptor Recycling	5/10	6.976960389464207E-10	4.451008712409175E-9	0	0	209.42105263157896	4415.273807367233	HGF;GAB1;GRB2;CRK;CRKL
Signaling by FGFR1 in Disease	7/38	7.015930824950526E-10	4.451008712409175E-9	0	0	48.242455775234134	1016.8384438797891	STAT3;GAB1;GRB2;PIK3R1;PLCG1;SOS1;FGFR1
Cell Cycle, Mitotic	17/516	7.05321908809137E-10	4.451008712409175E-9	0	0	7.963324238839124	167.80608938053695	RB1;LYN;CDKN1A;HSP90AA1;CDKN2B;HSP90AB1;CDKN2C;SRC;PTK6;CCND2;CDK6;CCNE1;MYC;CDK1;SKP2;JAK2;MAPK3
Signaling by FGFR in Disease	8/63	9.071159362465458E-10	5.681410337544156E-9	0	0	31.375494071146246	653.2613448546307	STAT3;GAB1;GRB2;PIK3R1;PLCG1;SOS1;FGFR4;FGFR1
SHC1 Events in ERBB2 Signaling	6/22	9.385304187224506E-10	5.834297304446279E-9	0	0	79.32446808510639	1648.8943846629518	ERBB3;SHC1;ERBB2;GRB2;SOS1;EGFR
Viral Infection Pathways	23/1029	1.0102530679439534E-9	6.233635597017134E-9	0	0	5.610002323720018	116.20034264200005	RB1;BECN1;HSP90AA1;HSP90AB1;CAV1;PTPN11;VAV1;RELA;EGFR;IGF1R;HCK;SP1;LCK;BTK;PLCG2;BLNK;GRB2;FYN;PTPN6;VHL;JAK2;SOS1;NCK1
MET Promotes Cell Motility	7/41	1.2346549238306154E-9	7.56226140846252E-9	0	0	43.979127134724855	902.120715958797	SRC;HGF;GAB1;GRB2;CRK;PTK2;CRKL
Interleukin-6 Signaling	5/11	1.2740619013297642E-9	7.690533071070242E-9	0	0	174.50877192982455	3574.1238767778955	SOCS3;STAT3;PTPN11;CBL;JAK2
MET Activates RAP1 and RAC1	5/11	1.2740619013297642E-9	7.690533071070242E-9	0	0	174.50877192982455	3574.1238767778955	HGF;GAB1;GRB2;CRK;CRKL
PI3K Cascade	7/44	2.078922419697571E-9	1.2458578241784723E-8	0	0	40.40714908456844	807.7961325798182	GAB1;PIK3R2;PTPN11;GRB2;PIK3R1;FGFR4;FGFR1
Signaling by PDGFRA Extracellular Domain Mutants	5/12	2.175484501424856E-9	1.282068571586744E-8	0	0	149.57142857142858	2983.3538737885965	STAT3;GRB2;PIK3R2;PIK3R1;SOS1
Signaling by PDGFRA Transmembrane, Juxtamembrane and Kinase Domain Mutants	5/12	2.175484501424856E-9	1.282068571586744E-8	0	0	149.57142857142858	2983.3538737885965	STAT3;GRB2;PIK3R2;PIK3R1;SOS1
Inactivation of CSF3 (G-CSF) Signaling	6/25	2.2009100328559953E-9	1.282068571586744E-8	0	0	66.78947368421052	1331.4077443064766	LYN;SOCS3;HCK;SOCS1;STAT3;JAK2
Interleukin-7 Signaling	6/25	2.2009100328559953E-9	1.282068571586744E-8	0	0	66.78947368421052	1331.4077443064766	SOCS1;HGF;STAT3;PIK3R3;PIK3R2;PIK3R1
MET Activates PTPN11	4/5	2.9299625387746827E-9	1.6949019408328545E-8	0	0	829.125	16290.877003827774	HGF;GAB1;GRB2;PTPN11
Transcriptional Regulation by RUNX2	9/106	2.977679850561884E-9	1.7106257348400338E-8	0	0	20.191118160190324	396.39448319138353	RB1;AR;CDKN1A;YES1;SRC;CDK1;STUB1;SKP2;MAPK3
Cell Cycle	18/649	3.227038382471242E-9	1.8411801182181814E-8	0	0	6.703297128058444	131.06086136159553	RB1;LYN;CDKN1A;HSP90AA1;CDKN2B;HSP90AB1;CDKN2C;SRC;PTK6;CCND2;CDK6;CCNE1;MYC;CDK1;MDM4;SKP2;JAK2;MAPK3
Integrin Signaling	6/27	3.649133337536311E-9	2.0678422246039097E-8	0	0	60.422492401215806	1173.935078642783	SHC1;SRC;GRB2;SOS1;CRK;PTK2
FLT3 Signaling in Disease	6/28	4.62567207184485E-9	2.6035032674640267E-8	0	0	57.67311411992263	1106.841884002455	CDKN1A;PTPN11;GRB2;PIK3R1;CBL;SOS1
Regulation of IFNG Signaling	5/14	5.455797470657816E-9	3.050120330911383E-8	0	0	116.32163742690058	2213.2037588561466	SOCS3;SOCS1;PTPN11;PTPN6;JAK2
Downregulation of ERBB2 Signaling	6/29	5.808911217086465E-9	3.225882029222017E-8	0	0	55.16281221091582	1046.1005475342995	HSP90AA1;ERBB3;CDC37;ERBB2;STUB1;EGFR
MET Activates PI3K AKT Signaling	4/6	8.756305301264766E-9	4.8304651099030135E-8	0	0	414.5416666666667	7691.195409208177	HGF;GAB1;GRB2;PIK3R1
Negative Regulation of FGFR4 Signaling	6/31	8.931530269150024E-9	4.894713627764454E-8	0	0	50.744680851063826	940.4855798769996	SRC;PTPN11;GRB2;CBL;FGFR4;MAPK3
Potential Therapeutics for SARS	10/164	9.57834985795322E-9	5.2148793671078644E-8	0	0	14.246753246753247	263.0486399710064	HSP90AA1;HSP90AB1;BTK;PLCG2;BLNK;GRB2;JAK2;SOS1;VAV1;NCK1
Signal Regulatory Protein Family Interactions	5/16	1.1809708936460002E-8	6.306081759019987E-8	0	0	95.16267942583733	1737.1322721698393	SRC;PTPN11;GRB2;PTPN6;PTK2
Signaling by FLT3 ITD and TKD Mutants	5/16	1.1809708936460002E-8	6.306081759019987E-8	0	0	95.16267942583733	1737.1322721698393	CDKN1A;PTPN11;GRB2;PIK3R1;SOS1
Spry Regulation of FGF Signaling	5/16	1.1809708936460002E-8	6.306081759019987E-8	0	0	95.16267942583733	1737.1322721698393	SRC;PTPN11;GRB2;CBL;MAPK3
Negative Regulation of FGFR1 Signaling	6/33	1.332760512433603E-8	7.07127074431332E-8	0	0	46.981087470449175	851.928184835787	SRC;PTPN11;GRB2;CBL;MAPK3;FGFR1
Aberrant Regulation of Mitotic G1 S Transition in Cancer Due to RB1 Defects	5/17	1.6664329868330147E-8	8.730431937307556E-8	0	0	87.2280701754386	1562.2543301775686	RB1;CDKN1A;CCND2;CDK6;CCNE1
Defective Binding of RB1 Mutants to E2F1,(E2F2, E2F3)	5/17	1.6664329868330147E-8	8.730431937307556E-8	0	0	87.2280701754386	1562.2543301775686	RB1;CDKN1A;CCND2;CDK6;CCNE1
EPH-Ephrin Signaling	8/92	1.9360467649976495E-8	1.0079543470269013E-7	0	0	20.51345755693582	364.31967494816774	VAV3;LYN;YES1;SRC;RASA1;FYN;PTK2;EPHA2
Erythropoietin Activates Phospholipase C Gamma (PLCG)	4/7	2.0353220377172602E-8	1.0530579238624085E-7	0	0	276.34722222222223	4894.11668073383	LYN;PLCG2;PLCG1;JAK2
Oxidative Stress Induced Senescence	8/94	2.296427241845562E-8	1.1761824505913311E-7	0	0	20.03437815975733	352.3912127034468	MAP2K3;CDKN2B;CDKN2C;CDK6;MDM4;MAPK14;MAP2K6;MAPK3
Aberrant Regulation of Mitotic Cell Cycle Due to RB1 Defects	6/36	2.315653324093377E-8	1.1761824505913311E-7	0	0	42.276595744680854	743.2643597897634	RB1;CDKN1A;CCND2;CDK6;CCNE1;SKP2
RHO GTPases Activate WASPs and WAVEs	6/36	2.315653324093377E-8	1.1761824505913311E-7	0	0	42.276595744680854	743.2643597897634	WAS;BTK;GRB2;PTK2;MAPK3;NCK1
NCAM Signaling for Neurite Out-Growth	7/63	2.7780729183799686E-8	1.4025059036427358E-7	0	0	26.672043010752688	464.0648293034006	SRC;FYN;GRB2;SOS1;PTK2;MAPK3;FGFR1
RAC1 GTPase Cycle	10/184	2.876107698751733E-8	1.4432516343736107E-7	0	0	12.596424010217113	218.72736564799916	VAV3;CAV1;WAS;PIK3R3;ABL2;PIK3R2;PIK3R1;SOS1;VAV1;EPHA2
Diseases of Mitotic Cell Cycle	6/38	3.255718140890647E-8	1.6239600068035385E-7	0	0	39.630319148936174	683.2373177278538	RB1;CDKN1A;CCND2;CDK6;CCNE1;SKP2
Platelet Aggregation (Plug Formation)	6/39	3.8321924864731144E-8	1.900128774542919E-7	0	0	38.42746615087041	656.2352024554509	SHC1;SRC;GRB2;SOS1;CRK;PTK2
PI-3K Cascade FGFR4	5/20	4.125948781479833E-8	2.0098920087559655E-7	0	0	69.7719298245614	1186.3589670673543	GAB1;PTPN11;GRB2;PIK3R1;FGFR4
Signaling by PDGFR in Disease	5/20	4.125948781479833E-8	2.0098920087559655E-7	0	0	69.7719298245614	1186.3589670673543	STAT3;PIK3R2;GRB2;PIK3R1;SOS1
Signalling to RAS	5/20	4.125948781479833E-8	2.0098920087559655E-7	0	0	69.7719298245614	1186.3589670673543	SHC1;SRC;GRB2;MAPK14;SOS1
RHOU GTPase Cycle	6/40	4.490330125051338E-8	2.1746773221905607E-7	0	0	37.29536921151439	630.9911964369484	SRC;PIK3R2;GRB2;PIK3R1;NCK1;EPHA2
PI-3K Cascade FGFR1	5/21	5.393912839422759E-8	2.597184621525525E-7	0	0	65.40789473684211	1094.6279146074917	GAB1;PTPN11;GRB2;PIK3R1;FGFR1
Toll Like Receptor 4 (TLR4) Cascade	9/148	5.5909605958164556E-8	2.67659205535351E-7	0	0	14.060320973990038	234.80074670853205	MAP2K3;SOCS1;BTK;PLCG2;PTPN11;MAPK14;RELA;MAP2K6;MAPK3
EPHB-mediated Forward Signaling	6/42	6.087524850447576E-8	2.897661828813046E-7	0	0	35.219858156028366	585.1581910270995	LYN;YES1;SRC;RASA1;FYN;PTK2
Signaling by FGFR3 in Disease	5/22	6.952779612445798E-8	3.2907189870269035E-7	0	0	61.55727554179567	1014.5586511243146	GAB1;GRB2;PIK3R1;PLCG1;SOS1
SHC-related Events Triggered by IGF1R	4/9	7.271156528405779E-8	3.421962366193228E-7	0	0	165.79166666666666	2725.0787274146833	SHC1;GRB2;SOS1;IGF1R
Netrin-1 Signaling	6/44	8.125995834190388E-8	3.8027834437531425E-7	0	0	33.36282194848824	544.6685016709359	SRC;FYN;PTPN11;PLCG1;PTK2;NCK1
Anti-inflammatory Response Favouring Leishmania Parasite Infection	9/159	1.0367722141110608E-7	4.797951413080632E-7	0	0	13.021978021978022	209.41923444142978	LYN;FGR;HCK;YES1;SRC;PLCG2;FYN;PLCG1;MAPK14
Leishmania Parasite Growth and Survival	9/159	1.0367722141110608E-7	4.797951413080632E-7	0	0	13.021978021978022	209.41923444142978	LYN;FGR;HCK;YES1;SRC;PLCG2;FYN;PLCG1;MAPK14
CD28 Dependent PI3K Akt Signaling	5/24	1.1133534201071883E-7	5.067887425952393E-7	0	0	55.07202216066482	881.7426765760633	LCK;PIK3R3;PIK3R2;FYN;PIK3R1
Interleukin-6 Family Signaling	5/24	1.1133534201071883E-7	5.067887425952393E-7	0	0	55.07202216066482	881.7426765760633	SOCS3;STAT3;PTPN11;CBL;JAK2
RUNX2 Regulates Osteoblast Differentiation	5/24	1.1133534201071883E-7	5.067887425952393E-7	0	0	55.07202216066482	881.7426765760633	RB1;AR;YES1;SRC;MAPK3
MAPK3 (ERK1) Activation	4/10	1.2072170882080684E-7	5.435739645823357E-7	0	0	138.15277777777777	2200.743061756685	CDK1;PTPN11;JAK2;MAPK3
Signal Attenuation	4/10	1.2072170882080684E-7	5.435739645823357E-7	0	0	138.15277777777777	2200.743061756685	SHC1;GRB2;SOS1;MAPK3
Senescence-Associated Secretory Phenotype (SASP)	7/81	1.6226053397495962E-7	7.266829290383944E-7	0	0	20.16594013368207	315.2755696135512	CDKN1A;CDKN2B;CDKN2C;CDK6;STAT3;RELA;MAPK3
FCGR3A-mediated IL10 Synthesis	8/121	1.6619219212191572E-7	7.403106739976245E-7	0	0	15.226625625240477	237.68946743341303	LYN;FGR;HCK;YES1;SRC;PLCG2;FYN;PLCG1
MET Activates RAS Signaling	4/11	1.8897870569801037E-7	8.329061473356753E-7	0	0	118.41071428571429	1833.191043808636	SHC1;HGF;GRB2;SOS1
Signaling by Leptin	4/11	1.8897870569801037E-7	8.329061473356753E-7	0	0	118.41071428571429	1833.191043808636	SOCS3;STAT3;PTPN11;JAK2
EPH-ephrin Mediated Repulsion of Cells	6/51	2.0154987540902773E-7	8.836370853458953E-7	0	0	28.163120567375888	434.19727817155456	VAV3;LYN;YES1;SRC;FYN;EPHA2
Toll-like Receptor Cascades	9/174	2.2391643060271403E-7	9.765569983877528E-7	0	0	11.82917082917083	181.1281801320447	MAP2K3;SOCS1;BTK;PLCG2;PTPN11;MAPK14;RELA;MAP2K6;MAPK3
CD28 Dependent Vav1 Pathway	4/12	2.823818698304803E-7	1.2187777076103114E-6	0	0	103.60416666666667	1562.3514066482542	LCK;FYN;GRB2;VAV1
Erythropoietin Activates Phosphoinositide-3-kinase (PI3K)	4/12	2.823818698304803E-7	1.2187777076103114E-6	0	0	103.60416666666667	1562.3514066482542	LYN;GAB1;PIK3R1;JAK2
RAC2 GTPase Cycle	7/88	2.8791719084994645E-7	1.2362629895773474E-6	0	0	18.41669985397584	277.36641961337006	VAV3;CAV1;PIK3R3;PIK3R2;PIK3R1;VAV1;EPHA2
EPHA-mediated Growth Cone Collapse	5/29	3.049719828171407E-7	1.2895515821658791E-6	0	0	43.58771929824562	653.9485543615966	LYN;YES1;SRC;FYN;EPHA2
Negative Regulation of FGFR3 Signaling	5/29	3.049719828171407E-7	1.2895515821658791E-6	0	0	43.58771929824562	653.9485543615966	SRC;PTPN11;GRB2;CBL;MAPK3
VEGFR2 Mediated Vascular Permeability	5/29	3.049719828171407E-7	1.2895515821658791E-6	0	0	43.58771929824562	653.9485543615966	VAV3;HSP90AA1;JUP;CAV1;VAV1
ERBB2 Activates PTK6 Signaling	4/13	4.0632190809492903E-7	1.709424997187252E-6	0	0	92.08796296296296	1355.1775240556426	ERBB3;ERBB2;PTK6;EGFR
RUNX2 Regulates Bone Development	5/31	4.3290430419407903E-7	1.8121069617772255E-6	0	0	40.23076923076923	589.4913692416433	RB1;AR;YES1;SRC;MAPK3
Role of LAT2 NTAL LAB on Calcium Mobilization	7/95	4.870812608813885E-7	2.028693451570983E-6	0	0	16.94574780058651	246.30364599049298	LYN;SHC1;PIK3R2;FYN;GRB2;PIK3R1;SOS1
DCC Mediated Attractive Signaling	4/14	5.666707862160507E-7	2.313905710382207E-6	0	0	82.875	1192.031512125974	SRC;FYN;PTK2;NCK1
Interleukin-15 Signaling	4/14	5.666707862160507E-7	2.313905710382207E-6	0	0	82.875	1192.031512125974	SHC1;STAT3;GRB2;SOS1
PTK6 Regulates RHO GTPases, RAS GTPase and MAP Kinases	4/14	5.666707862160507E-7	2.313905710382207E-6	0	0	82.875	1192.031512125974	RASA1;PXN;PTK6;CRK
SHC1 Events in EGFR Signaling	4/14	5.666707862160507E-7	2.313905710382207E-6	0	0	82.875	1192.031512125974	SHC1;GRB2;SOS1;EGFR
Bacterial Infection Pathways	8/143	5.997662897784454E-7	2.43709911895339E-6	0	0	12.731078904991948	182.3946762872212	MAP2K3;HSP90AA1;HSP90AB1;SRC;GRB2;CBL;MAP2K6;MAPK3
Interferon Gamma Signaling	7/99	6.456173156350435E-7	2.6106758442912195E-6	0	0	16.205703599812995	230.98084791361276	SOCS3;SOCS1;PTPN11;PTPN6;JAK2;CD44;MAPK3
Negative Regulation of FGFR2 Signaling	5/34	7.005822036110875E-7	2.819251089893893E-6	0	0	36.063520871143375	511.06892537274086	SRC;PTPN11;GRB2;CBL;MAPK3
GRB2 SOS Provides Linkage to MAPK Signaling for Integrins	4/15	7.697717176424293E-7	3.082787696135306E-6	0	0	75.33712121212122	1060.5336009814866	SRC;GRB2;SOS1;PTK2
Nuclear Events Stimulated by ALK Signaling in Cancer	5/35	8.141181753380749E-7	3.244786794529265E-6	0	0	34.85964912280702	488.7727284548838	RB1;ZAP70;STAT3;PTPN6;MAPK3
GRB2 Events in ERBB2 Signaling	4/16	1.022429274849078E-6	4.055636123568009E-6	0	0	69.05555555555556	952.506005361108	ERBB2;GRB2;SOS1;EGFR
Antiviral Mechanism by IFN-stimulated Genes	8/158	1.2771475994252645E-6	5.042009243228651E-6	0	0	11.44927536231884	155.37675811114764	BECN1;NEDD4;STAT3;CDK1;PLCG1;MAP2K6;NCK1;MAPK3
Platelet Sensitization by LDL	4/17	1.331899620230903E-6	5.2333603002468975E-6	0	0	63.74038461538461	862.3375666219024	FGR;PTPN11;PTPN6;MAPK14
G Alpha (Q) Signalling Events	9/219	1.5414541886584396E-6	6.0283161462557754E-6	0	0	9.273155416012559	124.10063879391502	BTK;PIK3R3;PIK3R2;GRB2;PIK3R1;SOS1;GRM1;EGFR;MAPK3
Gastrin-CREB Signalling Pathway via PKC and MAPK	4/18	1.7058808579487874E-6	6.609296533355069E-6	0	0	59.18452380952381	786.055047821626	GRB2;SOS1;EGFR;MAPK3
PI-3K Cascade FGFR3	4/18	1.7058808579487874E-6	6.609296533355069E-6	0	0	59.18452380952381	786.055047821626	GAB1;PTPN11;GRB2;PIK3R1
Cyclin E Associated Events During G1 S Transition	6/73	1.7435855822072015E-6	6.72410550916018E-6	0	0	18.89456970466815	250.5338107736021	RB1;CDKN1A;CCNE1;MYC;PTK6;SKP2
MyD88 MAL(TIRAP) Cascade Initiated on Plasma Membrane	7/115	1.7803660782147685E-6	6.8029584548298265E-6	0	0	13.793707686180804	182.6106414280396	MAP2K3;SOCS1;BTK;MAPK14;RELA;MAP2K6;MAPK3
Toll Like Receptor TLR6 TLR2 Cascade	7/115	1.7803660782147685E-6	6.8029584548298265E-6	0	0	13.793707686180804	182.6106414280396	MAP2K3;SOCS1;BTK;MAPK14;RELA;MAP2K6;MAPK3
Cyclin A Cdk2-associated Events at S Phase Entry	6/75	2.045889017738323E-6	7.781851834593713E-6	0	0	18.34505087881591	240.3142618906808	RB1;CDKN1A;CCNE1;MYC;PTK6;SKP2
Toll Like Receptor 2 (TLR2) Cascade	7/118	2.1163810448654064E-6	7.977128553723454E-6	0	0	13.418870483386613	175.32831798048198	MAP2K3;SOCS1;BTK;MAPK14;RELA;MAP2K6;MAPK3
Toll Like Receptor TLR1 TLR2 Cascade	7/118	2.1163810448654064E-6	7.977128553723454E-6	0	0	13.418870483386613	175.32831798048198	MAP2K3;SOCS1;BTK;MAPK14;RELA;MAP2K6;MAPK3
Signaling by FLT3 Fusion Proteins	4/19	2.15250350312219E-6	8.0767361175711E-6	0	0	55.236111111111114	720.769328837962	CDKN1A;GRB2;PIK3R1;SOS1
Signaling by FGFR2 in Disease	5/43	2.338821443560366E-6	8.7364944506089E-6	0	0	27.509695290858726	356.6869516489501	GAB1;GRB2;PIK3R1;PLCG1;SOS1
FLT3 Signaling Through SRC Family Kinases	3/6	2.3992967780572162E-6	8.922384893400274E-6	0	0	205.1237113402062	2654.3695150710146	HCK;LCK;FYN
G1 S Transition	7/121	2.5038446171562602E-6	9.269789182627399E-6	0	0	13.063761554423694	168.49225741331927	RB1;CDKN1A;CCNE1;MYC;CDK1;PTK6;SKP2
SHC-mediated Cascade FGFR4	4/20	2.680321068927162E-6	9.87923650626693E-6	0	0	51.78125	664.3313770708211	SHC1;GRB2;FGFR4;SOS1
SHC-mediated Cascade FGFR1	4/21	3.2983007697773018E-6	1.2103456128742257E-5	0	0	48.7328431372549	615.1109724012736	SHC1;GRB2;SOS1;FGFR1
FRS-mediated FGFR4 Signaling	4/22	4.015814340350795E-6	1.467181291891321E-5	0	0	46.023148148148145	571.8500607054012	PTPN11;GRB2;FGFR4;SOS1
Activated NTRK2 Signals Through PI3K	3/7	4.183531145546383E-6	1.5086066858182413E-5	0	0	153.83505154639175	1905.1478738541261	GAB1;GRB2;PIK3R1
PTK6 Promotes HIF1A Stabilization	3/7	4.183531145546383E-6	1.5086066858182413E-5	0	0	153.83505154639175	1905.1478738541261	PTK6;HIF1A;EGFR
Signaling by LTK in Cancer	3/7	4.183531145546383E-6	1.5086066858182413E-5	0	0	153.83505154639175	1905.1478738541261	PIK3R2;PIK3R1;MAPK3
FRS-mediated FGFR1 Signaling	4/23	4.842628966725328E-6	1.716557416715829E-5	0	0	43.598684210526315	533.5629998044093	PTPN11;GRB2;SOS1;FGFR1
Nephrin Family Interactions	4/23	4.842628966725328E-6	1.716557416715829E-5	0	0	43.598684210526315	533.5629998044093	PIK3R2;FYN;PIK3R1;NCK1
PI-3K Cascade FGFR2	4/23	4.842628966725328E-6	1.716557416715829E-5	0	0	43.598684210526315	533.5629998044093	GAB1;PTPN11;GRB2;PIK3R1
RAF-independent MAPK1 3 Activation	4/23	4.842628966725328E-6	1.716557416715829E-5	0	0	43.598684210526315	533.5629998044093	CDK1;PTPN11;JAK2;MAPK3
Activated NTRK3 Signals Through RAS	3/8	6.669353467633975E-6	2.3540556942962294E-5	0	0	123.0618556701031	1466.6496741086537	SHC1;GRB2;SOS1
Regulation of IFNA IFNB Signaling	4/25	6.865153777759796E-6	2.4129422349678945E-5	0	0	39.442460317460316	468.9334664055757	SOCS3;SOCS1;PTPN11;PTPN6
FCGR Activation	6/94	7.663921581396761E-6	2.671149237365482E-5	0	0	14.370406189555126	169.26882409056034	FGR;LYN;HCK;YES1;SRC;FYN
Signaling by TGF-beta Receptor Complex	6/94	7.663921581396761E-6	2.671149237365482E-5	0	0	14.370406189555126	169.26882409056034	CDKN2B;SP1;MYC;STUB1;CBL;MAPK3
RHOJ GTPase Cycle	5/55	8.0607185019985E-6	2.7935901259205564E-5	0	0	20.894736842105264	245.06408531138774	JUP;CAV1;WAS;PIK3R2;PIK3R1
Interleukin-20 Family Signaling	4/26	8.082295562387204E-6	2.7935901259205564E-5	0	0	37.64772727272727	441.4510238762915	SOCS3;STAT3;PTPN11;JAK2
Regulation of RUNX1 Expression and Activity	4/27	9.451584250126313E-6	3.2533759009732305E-5	0	0	36.00905797101449	416.60060929912464	CCND2;CDK6;SRC;PTPN11
Activated NTRK2 Signals Through RAS	3/9	9.967716330682825E-6	3.3752470339263384E-5	0	0	102.54639175257732	1180.940557869435	SHC1;GRB2;SOS1
EGFR Transactivation by Gastrin	3/9	9.967716330682825E-6	3.3752470339263384E-5	0	0	102.54639175257732	1180.940557869435	GRB2;SOS1;EGFR
Nef and Signal Transduction	3/9	9.967716330682825E-6	3.3752470339263384E-5	0	0	102.54639175257732	1180.940557869435	HCK;LCK;FYN
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	3/9	9.967716330682825E-6	3.3752470339263384E-5	0	0	102.54639175257732	1180.940557869435	DOK1;PTK6;CBL
STAT5 Activation Downstream of FLT3 ITD Mutants	3/10	1.4187907246385926E-5	4.784828638153634E-5	0	0	87.89248895434463	981.1544503878058	CDKN1A;GRB2;PTPN11
RHO GTPase Effectors	9/291	1.5441832682771178E-5	5.186712348688867E-5	0	0	6.880289922843114	76.22281251460207	AR;SRC;BTK;WAS;GRB2;MAPK14;PTK2;NCK1;MAPK3
GPCR Downstream Signalling	13/633	1.607526667744854E-5	5.377790016993829E-5	0	0	4.646644419725621	51.290723785081624	VAV3;SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;GRM1;VAV1;EGFR;BTK;GRB2;SOS1;MAPK3
FGFR1 Mutant Receptor Activation	4/31	1.6687556029356314E-5	5.560293668981524E-5	0	0	30.66820987654321	337.37629271966244	STAT3;GRB2;PIK3R1;FGFR1
MyD88-independent TLR4 Cascade	6/110	1.8904511041054184E-5	6.2489911496818E-5	0	0	12.14975450081833	132.1420662411292	MAP2K3;PTPN11;MAPK14;RELA;MAP2K6;MAPK3
TRIF (TICAM1)-mediated TLR4 Signaling	6/110	1.8904511041054184E-5	6.2489911496818E-5	0	0	12.14975450081833	132.1420662411292	MAP2K3;PTPN11;MAPK14;RELA;MAP2K6;MAPK3
Activated NTRK2 Signals Through FRS2 and FRS3	3/11	1.943756475353003E-5	6.399798988019966E-5	0	0	76.9020618556701	834.256871154208	GRB2;PTPN11;SOS1
SMAD2 SMAD3 SMAD4 Heterotrimer Regulates Transcription	4/36	3.0647360561549374E-5	1.0011471116772795E-4	0	0	25.869791666666668	268.86381386041506	CDKN2B;SP1;MYC;MAPK3
Transcriptional Regulation by the AP-2 (TFAP2) Family of Transcription Factors	4/36	3.0647360561549374E-5	1.0011471116772795E-4	0	0	25.869791666666668	268.86381386041506	CDKN1A;MYC;ERBB2;EGFR
GRB2 Events in EGFR Signaling	3/13	3.344768461719186E-5	1.0883563002390946E-4	0	0	61.51546391752577	633.9493354046144	GRB2;SOS1;EGFR
RHOH GTPase Cycle	4/37	3.423076487553643E-5	1.109503001607854E-4	0	0	25.08459595959596	257.92949230262207	ZAP70;JUP;LCK;CAV1
RHOG GTPase Cycle	5/74	3.462786095496357E-5	1.1180235726932037E-4	0	0	15.126620900076277	155.36328407117355	VAV3;CAV1;PIK3R1;VAV1;EPHA2
Prolonged ERK Activation Events	3/14	4.241532244475955E-5	1.3589216767878734E-4	0	0	55.9203373945642	563.0060062434084	CRK;CRKL;MAPK3
SHC1 Events in ERBB4 Signaling	3/14	4.241532244475955E-5	1.3589216767878734E-4	0	0	55.9203373945642	563.0060062434084	SHC1;GRB2;SOS1
Ub-specific Processing Proteases	7/190	4.751556075050592E-5	1.5164928009644225E-4	0	0	8.109700922498384	80.72763915720496	AR;BECN1;KAT2A;MYC;MDM4;SKP2;HIF1A
Signaling by GPCR	13/706	4.986252187310106E-5	1.5853236916142438E-4	0	0	4.1414307276376245	41.026010467190524	VAV3;SHC1;SRC;PIK3R3;PIK3R2;PIK3R1;GRM1;VAV1;EGFR;BTK;GRB2;SOS1;MAPK3
Signaling by RAF1 Mutants	4/41	5.1689501936938505E-5	1.6371617913866834E-4	0	0	22.368243243243242	220.78028382384923	SRC;ARAF;JAK2;MAPK3
p130Cas Linkage to MAPK Signaling for Integrins	3/15	5.2826809188518965E-5	1.6605559265674074E-4	0	0	51.25773195876289	504.8113501315131	SRC;CRK;PTK2
ERBB2 Regulates Cell Motility	3/15	5.2826809188518965E-5	1.6605559265674074E-4	0	0	51.25773195876289	504.8113501315131	ERBB3;ERBB2;EGFR
RND1 GTPase Cycle	4/42	5.69121176311189E-5	1.7755728084914622E-4	0	0	21.778508771929825	212.86319430179833	CAV1;PIK3R2;PIK3R1;EPHA2
RND3 GTPase Cycle	4/42	5.69121176311189E-5	1.7755728084914622E-4	0	0	21.778508771929825	212.86319430179833	CAV1;PIK3R2;PIK3R1;EPHA2
Deubiquitination	8/268	6.0133632113256684E-5	1.8690789384456276E-4	0	0	6.568561872909699	63.839467073746775	AR;BECN1;KAT2A;MYC;CDK1;MDM4;SKP2;HIF1A
RND2 GTPase Cycle	4/43	6.250942361496206E-5	1.9357007387086765E-4	0	0	21.219017094017094	205.40418572151412	CAV1;PIK3R2;PIK3R1;EPHA2
Sema3A PAK Dependent Axon Repulsion	3/16	6.478177589668101E-5	1.9986377526642698E-4	0	0	47.312450436161775	456.30427675438654	HSP90AA1;HSP90AB1;FYN
Uptake and Actions of Bacterial Toxins	4/44	6.849758769034262E-5	2.1054793559430036E-4	0	0	20.6875	198.3664801106035	MAP2K3;HSP90AA1;HSP90AB1;MAP2K6
Cellular Response to Chemical Stress	7/202	6.995000957415796E-5	2.1343720870063582E-4	0	0	7.606010476978219	72.77225249107397	CDKN1A;SP1;MYC;STAT3;PTK6;SKP2;RELA
Programmed Cell Death	7/202	6.995000957415796E-5	2.1343720870063582E-4	0	0	7.606010476978219	72.77225249107397	HSP90AA1;CDC37;STAT3;STUB1;PTK2;TP73;MAPK3
Transcriptional Regulation by RUNX3	5/86	7.140264441003715E-5	2.1707446275022243E-4	0	0	12.877842755035738	122.94702681081283	CDKN1A;KAT2A;SRC;MYC;TEAD2
Paradoxical Activation of RAF Signaling by Kinase Inactive BRAF	4/45	7.48930003693102E-5	2.244096018260266E-4	0	0	20.181910569105693	191.7170528748238	SRC;ARAF;JAK2;MAPK3
Signaling by RAS Mutants	4/45	7.48930003693102E-5	2.244096018260266E-4	0	0	20.181910569105693	191.7170528748238	SRC;ARAF;JAK2;MAPK3
Signaling by Moderate Kinase Activity BRAF Mutants	4/45	7.48930003693102E-5	2.244096018260266E-4	0	0	20.181910569105693	191.7170528748238	SRC;ARAF;JAK2;MAPK3
Signaling Downstream of RAS Mutants	4/45	7.48930003693102E-5	2.244096018260266E-4	0	0	20.181910569105693	191.7170528748238	SRC;ARAF;JAK2;MAPK3
SHC-mediated Cascade FGFR3	3/18	9.371291441807692E-5	2.7879592039377885E-4	0	0	41.0	380.2862565875762	SHC1;GRB2;SOS1
Signaling by Cytosolic FGFR1 Fusion Mutants	3/18	9.371291441807692E-5	2.7879592039377885E-4	0	0	41.0	380.2862565875762	STAT3;GRB2;PIK3R1
RHOA GTPase Cycle	6/149	1.0358369424193891E-4	3.070648302616908E-4	0	0	8.818776967713138	80.91343069335824	VAV3;JUP;CAV1;PIK3R2;PIK3R1;VAV1
Class I MHC Mediated Antigen Processing & Presentation	9/373	1.0591493655023437E-4	3.128622061927136E-4	0	0	5.3080545827798575	48.58395622186543	SOCS3;BECN1;SOCS1;NEDD4;BTK;CBLB;STUB1;VHL;SKP2
S Phase	6/150	1.0746778994043538E-4	3.163274523688434E-4	0	0	8.75709219858156	80.02510538362931	RB1;CDKN1A;CCNE1;MYC;PTK6;SKP2
RAC3 GTPase Cycle	5/94	1.0904721332769338E-4	3.198462278238331E-4	0	0	11.715552927261975	106.88953725388168	CAV1;ABL2;PIK3R2;PIK3R1;EPHA2
VEGFR2 Mediated Cell Proliferation	3/19	1.108806349755567E-4	3.2408269801627624E-4	0	0	38.43556701030928	350.03487252570744	SRC;RASA1;PLCG1
SCF(Skp2)-mediated Degradation of P27 P21	4/50	1.1356720906997502E-4	3.3077442361989224E-4	0	0	17.983695652173914	163.34798914770596	CDKN1A;CCNE1;PTK6;SKP2
Transcriptional Activity of SMAD2 SMAD3 SMAD4 Heterotrimer	4/51	1.2276194853078428E-4	3.5630907012593486E-4	0	0	17.60017730496454	158.4942334974267	CDKN2B;SP1;MYC;MAPK3
CDC42 GTPase Cycle	6/155	1.2866151736759353E-4	3.7213556933057433E-4	0	0	8.461088105097815	75.79718131633948	VAV3;JUP;CAV1;WAS;PIK3R2;PIK3R1
FRS-mediated FGFR3 Signaling	3/20	1.2997496316054035E-4	3.746337173450869E-4	0	0	36.1728320194057	323.6806038860264	PTPN11;GRB2;SOS1
MyD88 Cascade Initiated on Plasma Membrane	5/98	1.328033366878381E-4	3.7885335431838747E-4	0	0	11.209394453876627	100.06224230943795	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
Toll Like Receptor 10 (TLR10) Cascade	5/98	1.328033366878381E-4	3.7885335431838747E-4	0	0	11.209394453876627	100.06224230943795	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
Toll Like Receptor 5 (TLR5) Cascade	5/98	1.328033366878381E-4	3.7885335431838747E-4	0	0	11.209394453876627	100.06224230943795	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
SARS-CoV-1 Infection	6/157	1.3801370416432538E-4	3.9237343197571004E-4	0	0	8.34817528533183	74.19989737636622	RB1;BECN1;SP1;CAV1;VHL;RELA
CD209 (DC-SIGN) Signaling	3/21	1.5108790718152865E-4	4.237583389973514E-4	0	0	34.16151202749141	300.5409826909726	LYN;FYN;RELA
Interleukin-37 Signaling	3/21	1.5108790718152865E-4	4.237583389973514E-4	0	0	34.16151202749141	300.5409826909726	STAT3;PTPN11;PTPN6
Negative Regulation of MET Activity	3/21	1.5108790718152865E-4	4.237583389973514E-4	0	0	34.16151202749141	300.5409826909726	HGF;GRB2;CBL
Signal Transduction by L1	3/21	1.5108790718152865E-4	4.237583389973514E-4	0	0	34.16151202749141	300.5409826909726	EGFR;FGFR1;MAPK3
Signaling by TGFB Family Members	6/161	1.5833282108965074E-4	4.4258805358281565E-4	0	0	8.131091283459163	71.15364530432903	CDKN2B;SP1;MYC;STUB1;CBL;MAPK3
TRAF6 Mediated Induction of NFkB and MAP Kinases Upon TLR7 8 or 9 Activation	5/102	1.6033559543799543E-4	4.4668746153796055E-4	0	0	10.744981009224091	93.8922386262267	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
MyD88 Dependent Cascade Initiated on Endosome	5/103	1.6785377251901475E-4	4.6607397502779766E-4	0	0	10.634801288936627	92.44213133615925	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
Listeria Monocytogenes Entry Into Host Cells	3/22	1.7430999547730406E-4	4.823927781813764E-4	0	0	32.36190992946283	280.0818212549987	SRC;GRB2;CBL
SARS-CoV-2 Infection	8/313	1.7588201929883023E-4	4.851315300527337E-4	0	0	5.586600142551675	48.300052833445854	RB1;BECN1;HSP90AA1;HSP90AB1;CAV1;PTPN11;PTPN6;VHL
Toll Like Receptor 3 (TLR3) Cascade	5/106	1.9203213177993413E-4	5.279299200418651E-4	0	0	10.31735278791037	88.29433534191173	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
Activated TAK1 Mediates P38 MAPK Activation	3/23	1.9973029138903675E-4	5.437102376701556E-4	0	0	30.742268041237114	261.8793213001886	MAP2K3;MAPK14;MAP2K6
RHOBTB2 GTPase Cycle	3/23	1.9973029138903675E-4	5.437102376701556E-4	0	0	30.742268041237114	261.8793213001886	HSP90AA1;HSP90AB1;CDC37
SHC-mediated Cascade FGFR2	3/23	1.9973029138903675E-4	5.437102376701556E-4	0	0	30.742268041237114	261.8793213001886	SHC1;GRB2;SOS1
Toll Like Receptor 7 8 (TLR7 8) Cascade	5/107	2.0065411729293015E-4	5.444458622313055E-4	0	0	10.215686274509803	86.97561681605222	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
Estrogen-dependent Nuclear Events Downstream of ESR-membrane Signaling	3/24	2.2743640782365407E-4	6.151121029776099E-4	0	0	29.276877761413843	245.59318448881905	EGFR;PTK2;MAPK3
Toll Like Receptor 9 (TLR9) Cascade	5/110	2.28298833907696E-4	6.15446371019776E-4	0	0	9.922305764411028	83.19709621314455	MAP2K3;MAPK14;RELA;MAP2K6;MAPK3
Drug-mediated Inhibition of CDK4 CDK6 Activity	2/5	2.450871709985121E-4	6.501834822986006E-4	0	0	135.35374149659864	1125.3170126751409	CCND2;CDK6
GRB7 Events in ERBB2 Signaling	2/5	2.450871709985121E-4	6.501834822986006E-4	0	0	135.35374149659864	1125.3170126751409	ERBB3;ERBB2
PTK6 Expression	2/5	2.450871709985121E-4	6.501834822986006E-4	0	0	135.35374149659864	1125.3170126751409	PTK6;HIF1A
PTK6 Regulates Proteins Involved in RNA Processing	2/5	2.450871709985121E-4	6.501834822986006E-4	0	0	135.35374149659864	1125.3170126751409	KHDRBS1;PTK6
TFAP2 (AP-2) Family Regulates Transcription of Cell Cycle Factors	2/5	2.450871709985121E-4	6.501834822986006E-4	0	0	135.35374149659864	1125.3170126751409	CDKN1A;MYC
Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways	4/61	2.467423464107934E-4	6.524964271752092E-4	0	0	14.505116959064328	120.49641294473822	HSP90AB1;MAPK14;RELA;MAP2K6
FRS-mediated FGFR2 Signaling	3/25	2.5751452149389134E-4	6.788278367228211E-4	0	0	27.944704779756325	230.94718074554484	PTPN11;GRB2;SOS1
MAP Kinase Activation	4/63	2.79497344115111E-4	7.344520115075315E-4	0	0	14.012005649717514	114.65348518972715	MAP2K3;MAPK14;MAP2K6;MAPK3
Semaphorin Interactions	4/64	2.9699395180546117E-4	7.779747228111609E-4	0	0	13.777777777777779	111.90033879709756	HSP90AA1;HSP90AB1;ERBB2;FYN
Signaling by BRAF and RAF1 Fusions	4/65	3.1526265874562236E-4	8.206681085471981E-4	0	0	13.551229508196721	109.25142744049542	SRC;ARAF;JAK2;MAPK3
The Role of GTSE1 in G2 M Progression After G2 Checkpoint	4/65	3.1526265874562236E-4	8.206681085471981E-4	0	0	13.551229508196721	109.25142744049542	CDKN1A;HSP90AA1;HSP90AB1;CDK1
G0 and Early G1	3/27	3.251243529193447E-4	8.437027600679569E-4	0	0	25.61340206185567	205.70898832313847	CCNE1;MYC;CDK1
KEAP1-NFE2L2 Pathway	5/119	3.2882667376429956E-4	8.506603082163402E-4	0	0	9.134810710987995	73.26099713674138	CDKN1A;SP1;MYC;SKP2;RELA
Activated NTRK3 Signals Through PI3K	2/6	3.664321680484968E-4	9.391938337981472E-4	0	0	101.51020408163265	803.1179907171842	SRC;PIK3R1
PTK6 Regulates Cell Cycle	2/6	3.664321680484968E-4	9.391938337981472E-4	0	0	101.51020408163265	803.1179907171842	CCNE1;PTK6
Uptake and Function of Diphtheria Toxin	2/6	3.664321680484968E-4	9.391938337981472E-4	0	0	101.51020408163265	803.1179907171842	HSP90AA1;HSP90AB1
The Role of Nef in HIV-1 Replication and Disease Pathogenesis	3/29	4.032210189685461E-4	0.0010303162846650273	0	0	23.640761300555116	184.7767981808264	HCK;LCK;FYN
RHOB GTPase Cycle	4/70	4.188784573037018E-4	0.001067051238330225	0	0	12.521464646464647	97.39107248944859	JUP;CAV1;PIK3R2;PIK3R1
Dectin-2 Family	3/30	4.4640250260442E-4	0.0011268281353620662	0	0	22.764032073310425	175.60833452775756	LYN;PLCG2;FYN
MET Activates PTK2 Signaling	3/30	4.4640250260442E-4	0.0011268281353620662	0	0	22.764032073310425	175.60833452775756	SRC;HGF;PTK2
PD-1 Signaling	3/30	4.4640250260442E-4	0.0011268281353620662	0	0	22.764032073310425	175.60833452775756	LCK;PTPN11;PTPN6
Interleukin-17 Signaling	4/72	4.6642383261609493E-4	0.0011738098264930728	0	0	12.151960784313726	93.21059230650977	MAP2K3;MAPK14;MAP2K6;MAPK3
EGFR Downregulation	3/31	4.924436798304106E-4	0.0012355589918636508	0	0	21.949926362297496	167.17350275311443	GRB2;CBL;EGFR
C-type Lectin Receptors (CLRs)	5/131	5.111317635071766E-4	0.0012564607820131164	0	0	8.259816207184628	62.60018184811349	LYN;SRC;PLCG2;FYN;RELA
Activated NTRK2 Signals Through FYN	2/7	5.113327792346296E-4	0.0012564607820131164	0	0	81.20408163265306	615.4043164173056	SRC;FYN
Erythropoietin Activates STAT5	2/7	5.113327792346296E-4	0.0012564607820131164	0	0	81.20408163265306	615.4043164173056	LYN;JAK2
Replication of the SARS-CoV-1 Genome	2/7	5.113327792346296E-4	0.0012564607820131164	0	0	81.20408163265306	615.4043164173056	RB1;VHL
Replication of the SARS-CoV-2 Genome	2/7	5.113327792346296E-4	0.0012564607820131164	0	0	81.20408163265306	615.4043164173056	RB1;VHL
SOS-mediated Signalling	2/7	5.113327792346296E-4	0.0012564607820131164	0	0	81.20408163265306	615.4043164173056	GRB2;SOS1
STAT5 Activation	2/7	5.113327792346296E-4	0.0012564607820131164	0	0	81.20408163265306	615.4043164173056	GRB2;PTPN11
Transcriptional Regulation by RUNX1	6/202	5.343384137035765E-4	0.0013091291135737624	0	0	6.41684759009987	48.34761744232718	SOCS3;CCND2;CDK6;SRC;PTPN11;TP73
Regulation of Necroptotic Cell Death	3/32	5.414210691078273E-4	0.001322591643890968	0	0	21.191965872733736	159.39141404206075	HSP90AA1;CDC37;STUB1
Respiratory Syncytial Virus Infection Pathway	5/133	5.476879615601818E-4	0.0013339885145603257	0	0	8.129934210526315	61.05421933516331	BECN1;HSP90AA1;HSP90AB1;EGFR;IGF1R
ISG15 Antiviral Mechanism	4/76	5.728566057742373E-4	0.001391223185451719	0	0	11.474537037037036	85.65598609029966	BECN1;NEDD4;PLCG1;MAPK3
Interferon Alpha Beta Signaling	4/78	6.320694999065338E-4	0.0015305636436690193	0	0	11.163288288288289	82.23448822300136	SOCS3;SOCS1;PTPN11;PTPN6
SARS-CoV-2 Activates Modulates Innate and Adaptive Immune Responses	5/138	6.476704355271103E-4	0.0015567352410659993	0	0	7.822318955282944	57.432471548876535	BECN1;HSP90AA1;HSP90AB1;PTPN11;PTPN6
RAF Activation	3/34	6.484839479590657E-4	0.0015567352410659993	0	0	19.822746923844363	145.51627376631131	SRC;ARAF;JAK2
RIPK1-mediated Regulated Necrosis	3/34	6.484839479590657E-4	0.0015567352410659993	0	0	19.822746923844363	145.51627376631131	HSP90AA1;CDC37;STUB1
IFNG Signaling Activates MAPKs	2/8	6.795551666861537E-4	0.00160359618654268	0	0	67.66666666666667	493.5655481733249	JAK2;MAPK3
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs IMPs VICKZs) Bind RNA	2/8	6.795551666861537E-4	0.00160359618654268	0	0	67.66666666666667	493.5655481733249	MYC;CD44
Netrin Mediated Repulsion Signals	2/8	6.795551666861537E-4	0.00160359618654268	0	0	67.66666666666667	493.5655481733249	SRC;PTPN11
Regulation of NFE2L2 Gene Expression	2/8	6.795551666861537E-4	0.00160359618654268	0	0	67.66666666666667	493.5655481733249	MYC;RELA
SARS-CoV-1 Genome Replication and Transcription	2/8	6.795551666861537E-4	0.00160359618654268	0	0	67.66666666666667	493.5655481733249	RB1;VHL
SARS-CoV-2 Genome Replication and Transcription	2/8	6.795551666861537E-4	0.00160359618654268	0	0	67.66666666666667	493.5655481733249	RB1;VHL
Interleukin-1 Family Signaling	5/140	6.912718117983881E-4	0.0016266367774803877	0	0	7.705653021442495	56.07386328601843	STAT3;PTPN11;PTPN6;RELA;MAP2K6
G Alpha (12 13) Signalling Events	4/80	6.954983194111242E-4	0.0016273879215434452	0	0	10.868421052631579	79.02300659763786	VAV3;BTK;SOS1;VAV1
PKR-mediated Signaling	4/80	6.954983194111242E-4	0.0016273879215434452	0	0	10.868421052631579	79.02300659763786	STAT3;CDK1;NCK1;MAP2K6
RHOBTB GTPase Cycle	3/35	7.067159044822667E-4	0.001649003777125289	0	0	19.202319587628867	139.31055899468168	HSP90AA1;HSP90AB1;CDC37
Antigen Processing Ubiquitination & Proteasome Degradation	7/296	7.171478430902833E-4	0.0016686708192575584	0	0	5.107601294787365	36.98020067486684	SOCS3;SOCS1;NEDD4;CBLB;STUB1;VHL;SKP2
Oncogenic MAPK Signaling	4/82	7.633074945828872E-4	0.0017711285319987327	0	0	10.588675213675213	76.00391815281573	SRC;ARAF;JAK2;MAPK3
Signaling by High-Kinase Activity BRAF Mutants	3/36	7.681770335999374E-4	0.001777476302746522	0	0	18.619493908153704	133.5295206771706	SRC;ARAF;MAPK3
SARS-CoV-2-host Interactions	6/218	7.963060156295003E-4	0.0018374595873112845	0	0	5.927739863508631	42.29754787025331	BECN1;HSP90AA1;HSP90AB1;CAV1;PTPN11;PTPN6
RHOV GTPase Cycle	3/37	8.329373632247138E-4	0.0019166763081938857	0	0	18.070952092177077	128.13302753808438	PIK3R1;NCK1;EPHA2
Downregulation of ERBB4 Signaling	2/9	8.70867194754317E-4	0.0019712836229085493	0	0	57.99708454810496	408.64867956136595	SRC;NEDD4
EGFR Interacts With Phospholipase C-gamma	2/9	8.70867194754317E-4	0.0019712836229085493	0	0	57.99708454810496	408.64867956136595	PLCG1;EGFR
Interleukin-23 Signaling	2/9	8.70867194754317E-4	0.0019712836229085493	0	0	57.99708454810496	408.64867956136595	STAT3;JAK2
MAPK1 (ERK2) Activation	2/9	8.70867194754317E-4	0.0019712836229085493	0	0	57.99708454810496	408.64867956136595	PTPN11;JAK2
PI3K AKT Activation	2/9	8.70867194754317E-4	0.0019712836229085493	0	0	57.99708454810496	408.64867956136595	PIK3R2;PIK3R1
Respiratory Syncytial Virus Genome Replication	2/9	8.70867194754317E-4	0.0019712836229085493	0	0	57.99708454810496	408.64867956136595	HSP90AA1;HSP90AB1
Platelet Homeostasis	4/87	9.530771662039316E-4	0.002151526502568767	0	0	9.948293172690763	69.19848374830829	FGR;PTPN11;PTPN6;MAPK14
MAP2K and MAPK Activation	3/40	0.0010476950310726527	0.0023587296240095124	0	0	16.60323209807746	113.9174773737536	SRC;ARAF;MAPK3
Activation of the AP-1 Family of Transcription Factors	2/10	0.0010850384206118583	0.0024296693665851556	0	0	50.744897959183675	346.39177176286466	MAPK14;MAPK3
RHOBTB3 ATPase Cycle	2/10	0.0010850384206118583	0.0024296693665851556	0	0	50.744897959183675	346.39177176286466	CCNE1;VHL
Downstream TCR Signaling	4/91	0.001127082086093349	0.0025170492700154414	0	0	9.488984674329503	64.41239711328686	LCK;PIK3R2;PIK3R1;RELA
Death Receptor Signaling	5/157	0.001156056364697157	0.0025748528122800313	0	0	6.837950138504155	46.243284058606335	VAV3;STUB1;SOS1;VAV1;RELA
RHOF GTPase Cycle	3/42	0.001208590604538961	0.002684682596215879	0	0	15.750198255352895	105.81456304852415	CAV1;PIK3R2;PIK3R1
Cellular Responses to Mechanical Stimuli	4/93	0.0012219357767157717	0.0026999270610191988	0	0	9.274812734082397	62.20912744545419	PIK3R2;FYN;RELA;PTK2
Response of Endothelial Cells to Shear Stress	4/93	0.0012219357767157717	0.0026999270610191988	0	0	9.274812734082397	62.20912744545419	PIK3R2;FYN;RELA;PTK2
Regulation of TP53 Activity	5/160	0.0012574881900497678	0.00277113138177634	0	0	6.7045840407470285	44.777496772750624	CDK1;MDM4;MAPK14;MAP2K6;TP73
Assembly and Release of Respiratory Syncytial Virus (RSV) Virions	2/11	0.0013218400851343036	0.0028900073252411413	0	0	45.10430839002267	298.984305122014	HSP90AA1;HSP90AB1
Interleukin-27 Signaling	2/11	0.0013218400851343036	0.0028900073252411413	0	0	45.10430839002267	298.984305122014	STAT3;JAK2
STAT3 Nuclear Events Downstream of ALK Signaling	2/11	0.0013218400851343036	0.0028900073252411413	0	0	45.10430839002267	298.984305122014	STAT3;HIF1A
P75 NTR Receptor-Mediated Signalling	4/98	0.001483293475228356	0.0032345116881288497	0	0	8.779255319148936	57.18359473531712	VAV3;SOS1;VAV1;RELA
Early SARS-CoV-2 Infection Events	3/46	0.0015751859953084873	0.003403128088394213	0	0	14.282186526012946	92.16840432528492	RB1;BECN1;VHL
Frs2-mediated Activation	2/12	0.001581045102291189	0.003403128088394213	0	0	40.59183673469388	261.8039188938469	CRKL;MAPK3
GP1b-IX-V Activation Signalling	2/12	0.001581045102291189	0.003403128088394213	0	0	40.59183673469388	261.8039188938469	SRC;PIK3R1
Interleukin-2 Signaling	2/12	0.001581045102291189	0.003403128088394213	0	0	40.59183673469388	261.8039188938469	LCK;SHC1
Interleukin-35 Signalling	2/12	0.001581045102291189	0.003403128088394213	0	0	40.59183673469388	261.8039188938469	STAT3;JAK2
Cellular Response to Heat Stress	4/101	0.0016575407230688796	0.0035585861399906613	0	0	8.506443298969073	54.46182497940836	HSP90AA1;HSP90AB1;HSPA4;MAPK3
NOTCH1 Intracellular Domain Regulates Transcription	3/48	0.0017818416942912629	0.003815614733533733	0	0	13.646048109965635	86.3809554416349	KAT2A;MYC;HIF1A
eNOS Activation	2/13	0.0018624280503563755	0.003937569964332134	0	0	36.89981447124304	231.94759321375395	HSP90AA1;CAV1
p38MAPK Events	2/13	0.0018624280503563755	0.003937569964332134	0	0	36.89981447124304	231.94759321375395	SRC;MAPK14
Activation of RAC1	2/13	0.0018624280503563755	0.003937569964332134	0	0	36.89981447124304	231.94759321375395	SOS1;NCK1
Downregulation of ERBB2 ERBB3 Signaling	2/13	0.0018624280503563755	0.003937569964332134	0	0	36.89981447124304	231.94759321375395	ERBB3;ERBB2
TFAP2 (AP-2) Family Regulates Transcription of Growth Factors and Their Receptors	2/13	0.0018624280503563755	0.003937569964332134	0	0	36.89981447124304	231.94759321375395	ERBB2;EGFR
TP53 Regulates Transcription of Cell Cycle Genes	3/49	0.0018912091143729426	0.003988296689297876	0	0	13.348722545943524	83.70368414188104	CDKN1A;CCNE1;CDK1
Role of Phospholipids in Phagocytosis	4/107	0.0020478312922353925	0.004307685521293136	0	0	8.008495145631068	49.58038484161047	PLCG2;PIK3R2;PIK3R1;PLCG1
Golgi Cisternae Pericentriolar Stack Reorganization	2/14	0.0021657651600423137	0.004521509720088339	0	0	33.82312925170068	207.5042741698455	CDK1;MAPK3
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	2/14	0.0021657651600423137	0.004521509720088339	0	0	33.82312925170068	207.5042741698455	CDKN1A;CCNE1
Uptake and Function of Anthrax Toxins	2/14	0.0021657651600423137	0.004521509720088339	0	0	33.82312925170068	207.5042741698455	MAP2K3;MAP2K6
Transcriptional Regulation by TP53	7/362	0.0022775822080093795	0.004743064948179533	0	0	4.144025442980463	25.21490642649303	CDKN1A;CCNE1;CDK1;MDM4;MAPK14;MAP2K6;TP73
p53-Dependent G1 DNA Damage Response	3/53	0.0023702048008991446	0.00488708069096284	0	0	12.278350515463918	74.219914290735	CDKN1A;CCNE1;MDM4
p53-Dependent G1 S DNA Damage Checkpoint	3/53	0.0023702048008991446	0.00488708069096284	0	0	12.278350515463918	74.219914290735	CDKN1A;CCNE1;MDM4
RHOD GTPase Cycle	3/53	0.0023702048008991446	0.00488708069096284	0	0	12.278350515463918	74.219914290735	CAV1;PIK3R2;PIK3R1
Synthesis of PIPs at the Plasma Membrane	3/53	0.0023702048008991446	0.00488708069096284	0	0	12.278350515463918	74.219914290735	PIK3R3;PIK3R2;PIK3R1
Negative Regulation of FLT3	2/15	0.0024908343052083164	0.005097948344566406	0	0	31.21978021978022	187.16687708215863	ABL2;CBL
Phospholipase C-mediated Cascade; FGFR4	2/15	0.0024908343052083164	0.005097948344566406	0	0	31.21978021978022	187.16687708215863	PLCG1;FGFR4
Prolactin Receptor Signaling	2/15	0.0024908343052083164	0.005097948344566406	0	0	31.21978021978022	187.16687708215863	PTPN11;JAK2
G1 S DNA Damage Checkpoints	3/55	0.0026353413771885016	0.005367333416132082	0	0	11.804916732751785	70.10636130554923	CDKN1A;CCNE1;MDM4
Intrinsic Pathway for Apoptosis	3/55	0.0026353413771885016	0.005367333416132082	0	0	11.804916732751785	70.10636130554923	STAT3;MAPK3;TP73
HSP90 Chaperone Cycle for Steroid Hormone Receptors (SHR) in the Presence of Ligand	3/56	0.0027744926921681934	0.005636957103844159	0	0	11.581598910717759	68.1842009003188	AR;HSP90AA1;HSP90AB1
InlB-mediated Entry of Listeria Monocytogenes Into Host Cell	2/16	0.0028374149918175937	0.0057229217631575196	0	0	28.988338192419825	170.01259891772904	GRB2;CBL
Phospholipase C-mediated Cascade FGFR1	2/16	0.0028374149918175937	0.0057229217631575196	0	0	28.988338192419825	170.01259891772904	PLCG1;FGFR1
Platelet Adhesion to Exposed Collagen	2/16	0.0028374149918175937	0.0057229217631575196	0	0	28.988338192419825	170.01259891772904	LYN;FYN
Transcriptional Regulation of Granulopoiesis	3/58	0.0030661973063982524	0.0061694259812312665	0	0	11.159325210871602	64.58255414819172	CDKN1A;MYC;STAT3
L1CAM Interactions	4/120	0.0031028215275947083	0.006228073090328656	0	0	7.10632183908046	41.04215964376	SRC;EGFR;FGFR1;MAPK3
Estrogen-dependent Gene Expression	4/121	0.003196760719070875	0.006357155225417262	0	0	7.04522792022792	40.47918311911139	HSP90AA1;HSP90AB1;SP1;MYC
FOXO-mediated Transcription of Cell Cycle Genes	2/17	0.00320528834894988	0.006357155225417262	0	0	27.05442176870748	155.3722787250682	CDKN1A;CAV1
Formation of Senescence-Associated Heterochromatin Foci (SAHF)	2/17	0.00320528834894988	0.006357155225417262	0	0	27.05442176870748	155.3722787250682	RB1;CDKN1A
Metabolism of Nitric Oxide NOS3 Activation and Regulation	2/17	0.00320528834894988	0.006357155225417262	0	0	27.05442176870748	155.3722787250682	HSP90AA1;CAV1
The NLRP3 Inflammasome	2/17	0.00320528834894988	0.006357155225417262	0	0	27.05442176870748	155.3722787250682	HSP90AB1;RELA
NRAGE Signals Death Through JNK	3/59	0.0032188419242375347	0.006368872500926048	0	0	10.959499263622975	62.89364704662167	VAV3;SOS1;VAV1
DNA Damage Telomere Stress Induced Senescence	3/60	0.003376073956019611	0.006664145984275677	0	0	10.766684753119913	61.27365293527066	RB1;CDKN1A;CCNE1
Regulated Necrosis	3/61	0.003537936569638058	0.006967142228152487	0	0	10.580519018841095	59.718688304120505	HSP90AA1;CDC37;STUB1
Ephrin Signaling	2/19	0.004004045638803338	0.007847929452054541	0	0	23.869147659063625	131.7684366549516	SRC;FYN
SARS-CoV-1 Targets Host Intracellular Signalling and Regulatory Pathways	2/19	0.004004045638803338	0.007847929452054541	0	0	23.869147659063625	131.7684366549516	SP1;CAV1
Aberrant Regulation of Mitotic Exit in Cancer Due to RB1 Defects	2/20	0.004434499847536051	0.008671216838022371	0	0	22.541950113378686	122.13995997533476	RB1;SKP2
Chaperone Mediated Autophagy	2/22	0.005356496957732583	0.010400843743103128	0	0	20.285714285714285	106.08302856731788	HSP90AA1;HSP90AB1
E2F Mediated Regulation of DNA Replication	2/22	0.005356496957732583	0.010400843743103128	0	0	20.285714285714285	106.08302856731788	RB1;CDK1
ERK MAPK Targets	2/22	0.005356496957732583	0.010400843743103128	0	0	20.285714285714285	106.08302856731788	MAPK14;MAPK3
Azathioprine ADME	2/23	0.005847619592062275	0.01132806307020436	0	0	19.318756073858115	99.33164622370634	VAV3;VAV1
RHOC GTPase Cycle	3/74	0.006081441880416014	0.01172648399626514	0	0	8.637578045593147	44.073358237157414	JUP;CAV1;PIK3R1
Signaling by NOTCH1	3/74	0.006081441880416014	0.01172648399626514	0	0	8.637578045593147	44.073358237157414	KAT2A;MYC;HIF1A
APC C-mediated Degradation of Cell Cycle Proteins	3/75	0.006312136885679514	0.01211523047412681	0	0	8.517182130584192	43.1419208970586	RB1;CDK1;SKP2
Regulation of Mitotic Cell Cycle	3/75	0.006312136885679514	0.01211523047412681	0	0	8.517182130584192	43.1419208970586	RB1;CDK1;SKP2
RHO GTPases Activate NADPH Oxidases	2/24	0.006358547360763446	0.012176252762105632	0	0	18.43970315398887	93.26719485343038	MAPK14;MAPK3
Neddylation	5/234	0.0064301765983169785	0.012285176849536797	0	0	4.521029648356699	22.81652119038172	SOCS3;CDKN1A;VHL;SKP2;HIF1A
Cell Death Signalling via NRAGE, NRIF and NADE	3/76	0.006547998483950072	0.01248165386071032	0	0	8.400084733794662	42.240631240424875	VAV3;SOS1;VAV1
ADP Signalling Through P2Y Purinoceptor 1	2/25	0.006889074002829973	0.013071978688741156	0	0	17.637089618456077	87.79423275712823	SRC;MAPK14
Inflammasomes	2/25	0.006889074002829973	0.013071978688741156	0	0	17.637089618456077	87.79423275712823	HSP90AB1;RELA
Synthesis of IP3 and IP4 in the Cytosol	2/26	0.0074389947886241	0.014051434600734412	0	0	16.901360544217688	82.83389842043363	PLCG2;PLCG1
Translocation of ZAP-70 to Immunological Synapse	2/26	0.0074389947886241	0.014051434600734412	0	0	16.901360544217688	82.83389842043363	ZAP70;LCK
Attenuation Phase	2/27	0.008008106510589556	0.015024217845317793	0	0	16.224489795918366	78.32049478663112	HSP90AA1;HSP90AB1
Cell Recruitment (Pro-Inflammatory Response)	2/27	0.008008106510589556	0.015024217845317793	0	0	16.224489795918366	78.32049478663112	HSP90AB1;RELA
Purinergic Signaling in Leishmaniasis Infection	2/27	0.008008106510589556	0.015024217845317793	0	0	16.224489795918366	78.32049478663112	HSP90AB1;RELA
Autophagy	4/158	0.008176819501307596	0.015306271111436466	0	0	5.342532467532467	25.67862595978233	BECN1;HSP90AA1;HSP90AB1;SRC
PI Metabolism	3/84	0.008624169104403879	0.016107472789166886	0	0	7.567392134402444	35.9692273171892	PIK3R3;PIK3R2;PIK3R1
DDX58 IFIH1-mediated Induction of Interferon-Alpha Beta	3/86	0.009196704279318185	0.01707389798835247	0	0	7.384300086945721	34.62431918243145	HSP90AA1;HSP90AB1;RELA
G1 S-Specific Transcription	2/29	0.009203097475114358	0.01707389798835247	0	0	15.02116402116402	70.4224490277819	CCNE1;CDK1
Myogenesis	2/29	0.009203097475114358	0.01707389798835247	0	0	15.02116402116402	70.4224490277819	MAPK14;MAP2K6
CLEC7A (Dectin-1) Signaling	3/87	0.009491120371781655	0.017530162460519107	0	0	7.296023564064801	33.980490043633495	SRC;PLCG2;RELA
Nuclear Events Mediated by NFE2L2	3/87	0.009491120371781655	0.017530162460519107	0	0	7.296023564064801	33.980490043633495	SP1;MYC;RELA
HSF1 Activation	2/30	0.009828577820710147	0.018033491904518837	0	0	14.48396501457726	66.95156387938638	HSP90AA1;HSP90AB1
Regulation of CDH11 Expression and Function	2/30	0.009828577820710147	0.018033491904518837	0	0	14.48396501457726	66.95156387938638	JUP;SP1
Respiratory Syncytial Virus (RSV) Genome Replication, Transcription and Translation	2/30	0.009828577820710147	0.018033491904518837	0	0	14.48396501457726	66.95156387938638	HSP90AA1;HSP90AB1
Apoptosis	4/168	0.010088544445134748	0.018469796753400537	0	0	5.014227642276423	23.047168851593973	STAT3;PTK2;TP73;MAPK3
Neutrophil Degranulation	7/478	0.010141747050870798	0.018526480906524943	0	0	3.104878661278908	14.25479290570843	FGR;HSP90AA1;HSP90AB1;JUP;PTPN6;MAPK14;CD44
MAPK Targets Nuclear Events Mediated by MAP Kinases	2/31	0.010472451285062238	0.01904705659488394	0	0	13.983814215341308	63.75230908786907	MAPK14;MAPK3
Turbulent Flow Shear Stress Activates Signaling by PIEZO1 and Integrins in Endothelial Cells	2/31	0.010472451285062238	0.01904705659488394	0	0	13.983814215341308	63.75230908786907	RELA;PTK2
Respiratory Syncytial Virus (RSV) Attachment and Entry	2/32	0.011134522122224879	0.02016316723437679	0	0	13.517006802721088	60.79550767481704	EGFR;IGF1R
Thrombin Signalling Through Proteinase Activated Receptors (PARs)	2/32	0.011134522122224879	0.02016316723437679	0	0	13.517006802721088	60.79550767481704	SRC;MAPK3
Regulation of Expression and Function of Type II Classical Cadherins	2/33	0.011814596043916763	0.021256065884627782	0	0	13.08031599736669	58.0559303610333	JUP;SP1
Regulation of Homotypic Cell-Cell Adhesion	2/33	0.011814596043916763	0.021256065884627782	0	0	13.08031599736669	58.0559303610333	JUP;SP1
Signal Amplification	2/33	0.011814596043916763	0.021256065884627782	0	0	13.08031599736669	58.0559303610333	SRC;MAPK14
Diseases Associated With the TLR Signaling Cascade	2/35	0.013227983272248344	0.02369658078662983	0	0	12.286332714904143	53.14355844722063	BTK;RELA
Diseases of Immune System	2/35	0.013227983272248344	0.02369658078662983	0	0	12.286332714904143	53.14355844722063	BTK;RELA
G2 M Transition	4/184	0.013712096575505666	0.024511108256215063	0	0	4.564814814814815	19.5806675823033	CDKN1A;HSP90AA1;HSP90AB1;CDK1
Regulation of TP53 Degradation	2/36	0.013960915236479575	0.02490244623551924	0	0	11.92436974789916	50.93486932982207	CDK1;MDM4
Mitotic G2-G2 M Phases	4/186	0.014215997793159614	0.02530326102927769	0	0	4.51419413919414	19.200616217146138	CDKN1A;HSP90AA1;HSP90AB1;CDK1
HSF1-dependent Transactivation	2/37	0.014711087587821891	0.02601769843026674	0	0	11.583090379008746	48.87083992538764	HSP90AA1;HSP90AB1
NOD1 2 Signaling Pathway	2/37	0.014711087587821891	0.02601769843026674	0	0	11.583090379008746	48.87083992538764	MAPK14;MAP2K6
Regulation of TP53 Expression and Degradation	2/37	0.014711087587821891	0.02601769843026674	0	0	11.583090379008746	48.87083992538764	CDK1;MDM4
Cargo Recognition for Clathrin-Mediated Endocytosis	3/105	0.01574044098751093	0.027779210471602974	0	0	6.003032140691328	24.921720115184357	GRB2;CBL;EGFR
Association of TriC CCT With Target Proteins During Biosynthesis	2/39	0.016262406432153827	0.02863971365324342	0	0	10.955874241588527	45.126141525786544	CCNE1;STAT3
Transcriptional Regulation by VENTX	2/41	0.017880459748112743	0.03142283327041754	0	0	10.392987964416536	41.82186992516352	CSF1R;RELA
Mitotic Prophase	3/111	0.01823127953633176	0.03197190706055654	0	0	5.6678121420389465	22.697414047031366	RB1;CDK1;MAPK3
SARS-CoV-1-host Interactions	3/112	0.01866650187393652	0.03266637827938891	0	0	5.615530123900501	22.35556415568353	SP1;CAV1;RELA
Condensation of Prophase Chromosomes	2/42	0.01871405540009226	0.03268093951420724	0	0	10.13265306122449	40.31256172341721	RB1;CDK1
Negative Regulation of MAPK Pathway	2/43	0.01956378970919087	0.03409338248484518	0	0	9.885017421602788	38.888398778373954	ARAF;MAPK3
Signaling by NOTCH	4/209	0.020866029454326026	0.036286852892387436	0	0	4.003048780487805	15.490328970431317	KAT2A;MYC;HIF1A;EGFR
Signaling by ROBO Receptors	4/210	0.02119178444533636	0.03677657592284414	0	0	3.9834142394822005	15.352642923086638	SRC;ABL2;SOS1;NCK1
GPER1 Signaling	2/45	0.02131096041448218	0.036906507329030475	0	0	9.424299952539155	36.26973658038426	SHC1;SRC
Cell Junction Organization	3/119	0.021874299104735526	0.03780350861876493	0	0	5.274795591894774	20.16260489683167	JUP;SP1;PXN
Gastrulation	3/120	0.022355620001407114	0.03855534464010792	0	0	5.229447528416601	19.87544374344105	KAT2A;TEAD2;FGFR1
TGF-beta Receptor Signaling Activates SMADs	2/47	0.02312055761715071	0.03979219937001351	0	0	9.004535147392291	33.92038210413699	STUB1;CBL
Inositol Phosphate Metabolism	2/48	0.024048330053217173	0.04130362666872145	0	0	8.808340727595386	32.83476119194659	PLCG2;PLCG1
G2 M DNA Replication Checkpoint	1/5	0.024753528718293626	0.04208099882109916	0	0	50.24242424242424	185.83603697375267	CDK1
MET Interacts With TNS Proteins	1/5	0.024753528718293626	0.04208099882109916	0	0	50.24242424242424	185.83603697375267	HGF
NOSTRIN Mediated eNOS Trafficking	1/5	0.024753528718293626	0.04208099882109916	0	0	50.24242424242424	185.83603697375267	CAV1
NTRK2 Activates RAC1	1/5	0.024753528718293626	0.04208099882109916	0	0	50.24242424242424	185.83603697375267	FYN
Reelin Signalling Pathway	1/5	0.024753528718293626	0.04208099882109916	0	0	50.24242424242424	185.83603697375267	FYN
Signaling by NOTCH3	2/49	0.024991188433223118	0.04239849280015246	0	0	8.620495006513243	31.803005852102093	KAT2A;EGFR
Host Interactions of HIV Factors	3/126	0.025364692857154602	0.042944693394328826	0	0	4.972843852149862	18.272203113433353	HCK;LCK;FYN
Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha	2/53	0.028910084539220875	0.048848073876614585	0	0	7.942777110844338	28.145745374205482	VHL;HIF1A
Post-translational Protein Modification	13/1457	0.0294335680634231	0.04956343877017077	0	0	1.9098290190085012	6.733330402620815	BECN1;CDKN1A;HIF1A;RELA;AR;SOCS3;KAT2A;MYC;CDK1;KDELR2;MDM4;VHL;SKP2
CLEC7A Inflammasome Pathway	1/6	0.029630963394411815	0.04956343877017077	0	0	40.19191919191919	141.432767389918	RELA
MET Receptor Activation	1/6	0.029630963394411815	0.04956343877017077	0	0	40.19191919191919	141.432767389918	HGF
Negative Feedback Regulation of MAPK Pathway	1/6	0.029630963394411815	0.04956343877017077	0	0	40.19191919191919	141.432767389918	MAPK3
Phosphorylation of Emi1	1/6	0.029630963394411815	0.04956343877017077	0	0	40.19191919191919	141.432767389918	CDK1
MITF-M-regulated Melanocyte Development	3/136	0.030840345798215468	0.05148298206395488	0	0	4.596620417021937	15.991327643666999	CDKN1A;MAPK14;MAPK3
Interleukin-12 Family Signaling	2/56	0.03199941777272016	0.05320462076781615	0	0	7.500377928949358	25.81658262777106	STAT3;JAK2
Regulation of PTEN Stability and Activity	2/56	0.03199941777272016	0.05320462076781615	0	0	7.500377928949358	25.81658262777106	NEDD4;STUB1
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	2/58	0.0341280219187038	0.0553475521848659	0	0	7.2317784256559765	24.426318589638807	KAT2A;MYC
Constitutive Signaling by NOTCH1 PEST Domain Mutants	2/58	0.0341280219187038	0.0553475521848659	0	0	7.2317784256559765	24.426318589638807	KAT2A;MYC
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	2/58	0.0341280219187038	0.0553475521848659	0	0	7.2317784256559765	24.426318589638807	KAT2A;MYC
Signaling by NOTCH1 PEST Domain Mutants in Cancer	2/58	0.0341280219187038	0.0553475521848659	0	0	7.2317784256559765	24.426318589638807	KAT2A;MYC
Signaling by NOTCH1 in Cancer	2/58	0.0341280219187038	0.0553475521848659	0	0	7.2317784256559765	24.426318589638807	KAT2A;MYC
ARMS-mediated Activation	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	CRK
vRNP Assembly	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	HSP90AA1
Activation of NIMA Kinases NEK9, NEK6, NEK7	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	CDK1
Aryl Hydrocarbon Receptor Signalling	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	HSP90AB1
CDH11 Homotypic and Heterotypic Interactions	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	JUP
DEx H-box Helicases Activate Type I IFN and Inflammatory Cytokines Production	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	RELA
Epithelial-Mesenchymal Transition (EMT) During Gastrulation	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	FGFR1
FLT3 Signaling by CBL Mutants	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	CBL
IkBA Variant Leads to EDA-ID	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	RELA
RSK Activation	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	MAPK3
RUNX3 Regulates CDKN1A Transcription	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	CDKN1A
Regulation of CDH19 Expression and Function	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	JUP
Scavenging by Class F Receptors	1/7	0.03448424920041465	0.0553475521848659	0	0	33.49158249158249	112.77461836050252	HSP90AA1
Macroautophagy	3/143	0.035013664019419376	0.055870589867291036	0	0	4.365243004418262	14.632368293402916	BECN1;HSP90AA1;SRC
Adherens Junctions Interactions	2/59	0.03521255663904897	0.055870589867291036	0	0	7.104547081990691	23.774319154103356	JUP;SP1
Cytoprotection by HMOX1	2/59	0.03521255663904897	0.055870589867291036	0	0	7.104547081990691	23.774319154103356	STAT3;PTK6
Formation of Paraxial Mesoderm	2/59	0.03521255663904897	0.055870589867291036	0	0	7.104547081990691	23.774319154103356	KAT2A;FGFR1
RHOQ GTPase Cycle	2/59	0.03521255663904897	0.055870589867291036	0	0	7.104547081990691	23.774319154103356	JUP;CAV1
Regulation of RUNX2 Expression and Activity	2/59	0.03521255663904897	0.055870589867291036	0	0	7.104547081990691	23.774319154103356	STUB1;SKP2
Clathrin-mediated Endocytosis	3/145	0.03625711222134958	0.05730962899503643	0	0	4.3033251052708	14.27464455843759	GRB2;CBL;EGFR
PTEN Regulation	3/145	0.03625711222134958	0.05730962899503643	0	0	4.3033251052708	14.27464455843759	NEDD4;STUB1;MAPK3
APC C Cdh1 Mediated Degradation of Cdc20 and Other APC C Cdh1 Targets in Late Mitosis Early G1	2/61	0.03742130042373311	0.05892616872016952	0	0	6.863023175371843	22.54856700617945	RB1;SKP2
Nuclear Events (Kinase and Transcription Factor Activation)	2/61	0.03742130042373311	0.05892616872016952	0	0	6.863023175371843	22.54856700617945	MAPK14;MAPK3
Cellular Response to Hypoxia	2/62	0.03854519675936855	0.060420939038123796	0	0	6.7482993197278915	21.97194825947037	VHL;HIF1A
Binding of TCF LEF CTNNB1 to Target Gene Promoters	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	MYC
FGFR1b Ligand Binding and Activation	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	FGFR1
Gain-of-function MRAS Complexes Activate RAF Signaling	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	ARAF
Inhibition of Signaling by Overexpressed EGFR	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	EGFR
RUNX1 Regulates Transcription of Genes Involved in Differentiation of Keratinocytes	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	SOCS3
RUNX3 Regulates WNT Signaling	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	MYC
RUNX3 Regulates YAP1-mediated Transcription	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	TEAD2
Regulation of Cytoskeletal Remodeling and Cell Spreading by IPP Complex Components	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	PXN
Role of ABL in ROBO-SLIT Signaling	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	ABL2
SHOC2 M1731 Mutant Abolishes MRAS Complex Function	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	ARAF
Signaling by MRAS-complex Mutants	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	ARAF
Signaling by Overexpressed Wild-Type EGFR in Cancer	1/8	0.03931350415205654	0.060420939038123796	0	0	28.705627705627705	92.89678500716381	EGFR
Cell Cycle Checkpoints	4/261	0.04205422265544893	0.0645141205745653	0	0	3.184662775616083	10.091545001489377	CDKN1A;CCNE1;CDK1;MDM4
Activation of PUMA and Translocation to Mitochondria	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	TP73
BH3-only Proteins Associate With and Inactivate Anti-Apoptotic BCL-2 Members	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	STAT3
CD163 Mediating an Anti-Inflammatory Response	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	MAPK14
E2F-enabled Inhibition of Pre-Replication Complex Formation	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	CDK1
Interleukin-1 Processing	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	RELA
Interleukin-9 Signaling	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	STAT3
PI5P Regulates TP53 Acetylation	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	MAP2K6
Regulation of PTEN Localization	1/9	0.0441188457824273	0.06669872692697267	0	0	25.116161616161616	78.3842312444799	NEDD4
FOXO-mediated Transcription	2/67	0.04435377617601188	0.06693241948300344	0	0	6.227629513343799	19.402537395096388	CDKN1A;CAV1
High Laminar Flow Shear Stress Activates Signaling by PIEZO1 and PECAM1 CDH5 KDR in Endothelial Cell	2/69	0.04676264021877073	0.0701860888328577	0	0	6.041120925982333	18.501963939065423	PIK3R2;FYN
Loss of Nlp From Mitotic Centrosomes	2/69	0.04676264021877073	0.0701860888328577	0	0	6.041120925982333	18.501963939065423	HSP90AA1;CDK1
Loss of Proteins Required for Interphase Microtubule Organization From the Centrosome	2/69	0.04676264021877073	0.0701860888328577	0	0	6.041120925982333	18.501963939065423	HSP90AA1;CDK1
CD22 Mediated BCR Regulation	2/70	0.04798478677458479	0.0718908765885416	0	0	5.951980792316927	18.075399411278084	LYN;PTPN6
Activation of PPARGC1A (PGC-1alpha) by Phosphorylation	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	MAPK14
InlA-mediated Entry of Listeria Monocytogenes Into Host Cells	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	SRC
Interleukin-21 Signaling	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	STAT3
MASTL Facilitates Mitotic Progression	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	CDK1
Nef Mediated CD4 Down-regulation	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	LCK
PI3K Events in ERBB4 Signaling	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	PIK3R1
Regulation of CDH11 Gene Transcription	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	SP1
Regulation of Commissural Axon Pathfinding by SLIT and ROBO	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	SRC
Role of Second Messengers in Netrin-1 Signaling	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	PLCG1
Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage and Regulation	1/10	0.04890039114183046	0.07196824350025578	0	0	22.32435465768799	67.37423003045056	HSP90AA1
AURKA Activation by TPX2	2/72	0.05046378284153568	0.07413815010052774	0	0	5.78134110787172	17.265971584773993	HSP90AA1;CDK1
Condensation of Prometaphase Chromosomes	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	CDK1
Formation of Apoptosome	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	MAPK3
NFE2L2 Regulating Tumorigenic Genes	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	SP1
Receptor Mediated Mitophagy	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	SRC
Regulated Proteolysis of p75NTR	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	RELA
Regulation of CDH11 Function	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	JUP
Regulation of Gene Expression by Hypoxia-inducible Factor	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	HIF1A
Regulation of the Apoptosome Activity	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	MAPK3
Signaling by Activated Point Mutants of FGFR1	1/11	0.05365825675086383	0.07748664932904618	0	0	20.09090909090909	58.768318421882675	FGFR1
SUMO E3 Ligases SUMOylate Target Proteins	3/170	0.05367322528554579	0.07748664932904618	0	0	3.6544848447435028	10.688787107211333	AR;VHL;RELA
SUMOylation	3/176	0.0583548847938619	0.08343224922333778	0	0	3.526667063941362	10.020009516851996	AR;VHL;RELA
Hyaluronan Uptake and Degradation	1/12	0.05839255858007915	0.08343224922333778	0	0	18.26354453627181	51.878818604154176	CD44
SUMOylation of Immune Response Proteins	1/12	0.05839255858007915	0.08343224922333778	0	0	18.26354453627181	51.878818604154176	RELA
Suppression of Apoptosis	1/12	0.05839255858007915	0.08343224922333778	0	0	18.26354453627181	51.878818604154176	MAPK3
TP53 Regulates Transcription of Caspase Activators and Caspases	1/12	0.05839255858007915	0.08343224922333778	0	0	18.26354453627181	51.878818604154176	TP73
TP53 Regulates Transcription of Death Receptors and Ligands	1/12	0.05839255858007915	0.08343224922333778	0	0	18.26354453627181	51.878818604154176	TP73
RNA Polymerase I Promoter Clearance	2/79	0.05948975459677175	0.08470934287027498	0	0	5.253909355950173	14.8262756693766	KAT2A;MAPK3
Switching of Origins to a Post-Replicative State	2/79	0.05948975459677175	0.08470934287027498	0	0	5.253909355950173	14.8262756693766	CCNE1;SKP2
MAPK6 MAPK4 Signaling	2/80	0.0608217071927091	0.08631087238760934	0	0	5.1862899005756145	14.520618689888993	MYC;CDK1
Post NMDA Receptor Activation Events	2/80	0.0608217071927091	0.08631087238760934	0	0	5.1862899005756145	14.520618689888993	SRC;MAPK3
Centrosome Maturation	2/81	0.06216388427865964	0.0877669756002093	0	0	5.120382330147248	14.224325268693594	HSP90AA1;CDK1
RNA Polymerase I Transcription	2/81	0.06216388427865964	0.0877669756002093	0	0	5.120382330147248	14.224325268693594	KAT2A;MAPK3
Recruitment of Mitotic Centrosome Proteins and Complexes	2/81	0.06216388427865964	0.0877669756002093	0	0	5.120382330147248	14.224325268693594	HSP90AA1;CDK1
Advanced Glycosylation Endproduct Receptor Signaling	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	MAPK3
Chk1 Chk2(Cds1) Mediated Inactivation of Cyclin B Cdk1 Complex	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	CDK1
Cytochrome C-Mediated Apoptotic Response	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	MAPK3
ERKs Are Inactivated	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	MAPK3
Inhibition of Replication Initiation of Damaged DNA by RB1 E2F1	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	RB1
NF-kB Is Activated and Signals Survival	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	RELA
POU5F1 (OCT4), SOX2, NANOG Activate Genes Related to Proliferation	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	STAT3
Phospholipase C-mediated Cascade; FGFR3	1/13	0.06310341209244187	0.08790157570736469	0	0	16.74074074074074	46.254339159717055	PLCG1
Regulation of HSF1-mediated Heat Shock Response	2/83	0.06487838023453162	0.0902231898754004	0	0	4.99344923154447	13.658286245847663	HSPA4;MAPK3
AKT Phosphorylates Targets in the Cytosol	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	CDKN1A
FGFR1c Ligand Binding and Activation	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	FGFR1
FGFR4 Ligand Binding and Activation	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	FGFR4
Formation of Axial Mesoderm	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	TEAD2
RUNX3 Regulates NOTCH Signaling	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	KAT2A
Regulation of TP53 Activity Through Association With Co-factors	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	TP73
Repression of WNT Target Genes	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	MYC
SEMA3A-Plexin Repulsion Signaling by Inhibiting Integrin Adhesion	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	FYN
TP53 Regulates Transcription of Cell Death Genes With Uncertain Role in P53-Dependent Apoptosis	1/14	0.0677909321684321	0.0928780370004999	0	0	15.452214452214452	41.58695944336839	TP73
Regulation of PLK1 Activity at G2 M Transition	2/87	0.07042427630090098	0.0963274583885887	0	0	4.75750300120048	12.622688988987855	HSP90AA1;CDK1
YAP1- and WWTR1 (TAZ)-stimulated Gene Expression	1/15	0.07245523317560384	0.0986196229334608	0	0	14.347763347763347	37.659813836990104	TEAD2
Depolymerization of the Nuclear Lamina	1/15	0.07245523317560384	0.0986196229334608	0	0	14.347763347763347	37.659813836990104	CDK1
SARS-CoV-2 Targets Host Intracellular Signalling and Regulatory Pathways	1/15	0.07245523317560384	0.0986196229334608	0	0	14.347763347763347	37.659813836990104	CAV1
Selective Autophagy	2/89	0.07325362038573542	0.09954366359105646	0	0	4.647665962936899	12.148197603177868	HSP90AA1;SRC
Chaperonin-mediated Protein Folding	2/91	0.07611921823712782	0.103269232559491	0	0	4.542765420775051	11.699685676018186	CCNE1;STAT3
p75NTR Signals via NF-kB	1/16	0.0770964289305897	0.1037501216464963	0	0	13.390572390572391	34.31599732708391	RELA
CRMPs in Sema3A Signaling	1/16	0.0770964289305897	0.1037501216464963	0	0	13.390572390572391	34.31599732708391	FYN
Regulation of BACH1 Activity	1/16	0.0770964289305897	0.1037501216464963	0	0	13.390572390572391	34.31599732708391	SKP2
Regulation of Gene Expression in Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells	1/16	0.0770964289305897	0.1037501216464963	0	0	13.390572390572391	34.31599732708391	KAT2A
Transcription of E2F Targets Under Neg Control by P107 (RBL1) and P130 (RBL2) in Complex With HDAC1	1/16	0.0770964289305897	0.1037501216464963	0	0	13.390572390572391	34.31599732708391	CDK1
Cell-cell Junction Organization	2/92	0.07756530306155492	0.10404492343039491	0	0	4.492063492063492	11.484567093173027	JUP;SP1
Regulation of TP53 Activity Through Phosphorylation	2/92	0.07756530306155492	0.10404492343039491	0	0	4.492063492063492	11.484567093173027	MDM4;MAPK14
Activation of NMDA Receptors and Postsynaptic Events	2/93	0.07902008216924429	0.10582592997906833	0	0	4.442475891455484	11.27524039277228	SRC;MAPK3
MITF-M-dependent Gene Expression	2/94	0.08048343457235077	0.1074402259595644	0	0	4.39396628216504	11.071493966406615	CDKN1A;MAPK14
Recruitment of NuMA to Mitotic Centrosomes	2/94	0.08048343457235077	0.1074402259595644	0	0	4.39396628216504	11.071493966406615	HSP90AA1;CDK1
Hyaluronan Metabolism	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	CD44
IL-6-type Cytokine Receptor Ligand Interactions	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	JAK2
KSRP (KHSRP) Binds and Destabilizes mRNA	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	MAPK14
RIP-mediated NFkB Activation via ZBP1	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	RELA
Regulation of MITF-M-dependent Genes Involved in Cell Cycle and Proliferation	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	CDKN1A
Signaling by Activin	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	MAPK3
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676	1/17	0.08171463267155567	0.10787367514327396	0	0	12.553030303030303	31.43934295429433	BECN1
Anchoring of the Basal Body to the Plasma Membrane	2/97	0.08492373600454328	0.11175588008180815	0	0	4.254564983888292	10.49176426482804	HSP90AA1;CDK1
Protein Folding	2/97	0.08492373600454328	0.11175588008180815	0	0	4.254564983888292	10.49176426482804	CCNE1;STAT3
Activation of IRF3, IRF7 Mediated by TBK1, IKK? (IKBKE)	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	PTPN11
Cell-extracellular Matrix Interactions	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	PXN
FGFR1 Ligand Binding and Activation	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	FGFR1
G Beta Gamma Signalling Through BTK	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	BTK
Phospholipase C-mediated Cascade; FGFR2	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	PLCG1
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	CDK1
Translation of Replicase and Assembly of the Replication Transcription Complex 9679504	1/18	0.08630995715059277	0.1123378036038184	0	0	11.81402257872846	28.942114306609312	BECN1
Phospholipid Metabolism	3/211	0.08925183079658232	0.1159856085078831	0	0	2.928033306899286	7.074987394587304	PIK3R3;PIK3R2;PIK3R1
Metabolism of Proteins	15/2067	0.08972896707632547	0.11642403360526342	0	0	1.5349157206742345	3.7006229066053393	BECN1;CDKN1A;STAT3;HIF1A;RELA;AR;SOCS3;KAT2A;CCNE1;MYC;CDK1;KDELR2;MDM4;VHL;SKP2
Initiation of Nuclear Envelope (NE) Reformation	1/19	0.09088251453617983	0.11719061084928452	0	0	11.15712682379349	26.75688382123247	CDK1
MyD88 Deficiency (TLR2 4)	1/19	0.09088251453617983	0.11719061084928452	0	0	11.15712682379349	26.75688382123247	BTK
Regulation of TP53 Activity Through Methylation	1/19	0.09088251453617983	0.11719061084928452	0	0	11.15712682379349	26.75688382123247	MDM4
Transcription of E2F Targets Under Negative Control by DREAM Complex	1/19	0.09088251453617983	0.11719061084928452	0	0	11.15712682379349	26.75688382123247	MYC
Interleukin-1 Signaling	2/102	0.09248468910980343	0.11907225043039606	0	0	4.040816326530612	9.620020610565179	RELA;MAP2K6
Apoptotic Factor-Mediated Response	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	MAPK3
IRAK4 Deficiency (TLR2 4)	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	BTK
NOTCH4 Intracellular Domain Regulates Transcription	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	KAT2A
Phosphorylation of the APC C	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	CDK1
Sema4D Induced Cell Migration and Growth-Cone Collapse	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	ERBB2
Signaling by Hippo	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	LATS2
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	1/20	0.09543241646248146	0.12155229803248785	0	0	10.569377990430622	24.83103038927071	TP73
ZBP1(DAI) Mediated Induction of Type I IFNs	1/21	0.0999597740324998	0.12712441491461426	0	0	10.04040404040404	23.122924333288797	RELA
Synthesis of DNA	2/108	0.10180507197730584	0.1292738185321582	0	0	3.81093569503273	8.70682707358352	CCNE1;SKP2
Drug ADME	2/109	0.1033831480896997	0.13107787269211546	0	0	3.7751287430860194	8.566949896272241	VAV3;VAV1
NPAS4 Regulates Expression of Target Genes	1/22	0.10446469781910508	0.13204718252399777	0	0	9.561808561808562	21.59922753970687	MAPK3
Nef-mediates Down Modulation of Cell Surface Receptors by Recruiting Them to Clathrin Adapters	1/22	0.10446469781910508	0.13204718252399777	0	0	9.561808561808562	21.59922753970687	LCK
HIV Infection	3/227	0.10524883396721406	0.13283678590104442	0	0	2.716678939617084	6.116406719727853	HCK;LCK;FYN
Long-term Potentiation	1/23	0.10894729783603285	0.1370892735610504	0	0	9.1267217630854	20.232947516534363	SRC
Signaling by NODAL	1/23	0.10894729783603285	0.1370892735610504	0	0	9.1267217630854	20.232947516534363	MAPK3
APC C Cdc20 Mediated Degradation of Cyclin B	1/24	0.11340768358102403	0.14184474537986938	0	0	8.729468599033817	19.002011610155247	CDK1
Other Interleukin Signaling	1/24	0.11340768358102403	0.14184474537986938	0	0	8.729468599033817	19.002011610155247	CSF1R
Sema4D in Semaphorin Signaling	1/24	0.11340768358102403	0.14184474537986938	0	0	8.729468599033817	19.002011610155247	ERBB2
Triglyceride Catabolism	1/24	0.11340768358102403	0.14184474537986938	0	0	8.729468599033817	19.002011610155247	CAV1
M Phase	4/372	0.11625508707881302	0.14518813723635868	0	0	2.2115036231884058	4.759086080896843	RB1;HSP90AA1;CDK1;MAPK3
Chromatin Modifying Enzymes	3/238	0.11685610049619337	0.14543064895655006	0	0	2.588067558675148	5.556094521365731	KAT2A;JAK2;RELA
Chromatin Organization	3/238	0.11685610049619337	0.14543064895655006	0	0	2.588067558675148	5.556094521365731	KAT2A;JAK2;RELA
Basigin Interactions	1/25	0.11784596404042172	0.14543064895655006	0	0	8.365319865319865	17.88820673407011	CAV1
Cyclin A B1 B2 Associated Events During G2 M Transition	1/25	0.11784596404042172	0.14543064895655006	0	0	8.365319865319865	17.88820673407011	CDK1
Metabolism of Cofactors	1/25	0.11784596404042172	0.14543064895655006	0	0	8.365319865319865	17.88820673407011	HSP90AA1
NOTCH3 Activation and Transmission of Signal to the Nucleus	1/25	0.11784596404042172	0.14543064895655006	0	0	8.365319865319865	17.88820673407011	EGFR
NOTCH3 Intracellular Domain Regulates Transcription	1/25	0.11784596404042172	0.14543064895655006	0	0	8.365319865319865	17.88820673407011	KAT2A
TRAF6 Mediated NF-kB Activation	1/25	0.11784596404042172	0.14543064895655006	0	0	8.365319865319865	17.88820673407011	RELA
Constitutive Signaling by AKT1 E17K in Cancer	1/26	0.12226224762866918	0.15043493689022366	0	0	8.030303030303031	16.876380218002918	CDKN1A
Downregulation of TGF-beta Receptor Signaling	1/26	0.12226224762866918	0.15043493689022366	0	0	8.030303030303031	16.876380218002918	STUB1
Cardiogenesis	1/27	0.12665664230282664	0.1556120693779566	0	0	7.721056721056721	15.953830010816358	KAT2A
CREB1 Phosphorylation Through NMDA Receptor-Mediated Activation of RAS Signaling	1/28	0.1310292553948657	0.16027513912470356	0	0	7.434717545828657	15.109834134055738	MAPK3
Notch-HLH Transcription Pathway	1/28	0.1310292553948657	0.16027513912470356	0	0	7.434717545828657	15.109834134055738	KAT2A
TGFBR3 Expression	1/28	0.1310292553948657	0.16027513912470356	0	0	7.434717545828657	15.109834134055738	SP1
PIWI-interacting RNA (piRNA) Biogenesis	1/29	0.13538019382269004	0.16511230081156777	0	0	7.1688311688311686	14.335283778329618	HSP90AA1
Phosphorylation of CD3 and TCR Zeta Chains	1/29	0.13538019382269004	0.16511230081156777	0	0	7.1688311688311686	14.335283778329618	LCK
Activation of BH3-only Proteins	1/30	0.13970956391884184	0.1696473276157365	0	0	6.921281783350749	13.622394510819323	TP73
Regulation of TP53 Activity Through Acetylation	1/30	0.13970956391884184	0.1696473276157365	0	0	6.921281783350749	13.622394510819323	MAP2K6
SUMOylation of Intracellular Receptors	1/30	0.13970956391884184	0.1696473276157365	0	0	6.921281783350749	13.622394510819323	AR
Antigen Presentation Folding, Assembly and Peptide Loading of Class I MHC	1/31	0.14401747150131122	0.173864570667525	0	0	6.69023569023569	12.964476920040203	BECN1
Disassembly of the Destruction Complex and Recruitment of AXIN to the Membrane	1/31	0.14401747150131122	0.173864570667525	0	0	6.69023569023569	12.964476920040203	CAV1
Downregulation of SMAD2 3 SMAD4 Transcriptional Activity	1/31	0.14401747150131122	0.173864570667525	0	0	6.69023569023569	12.964476920040203	MAPK3
RNA Polymerase I Promoter Opening	1/31	0.14401747150131122	0.173864570667525	0	0	6.69023569023569	12.964476920040203	MAPK3
Epigenetic Regulation by WDR5-containing Histone Modifying Complexes	2/135	0.14649414671912903	0.17659858786835672	0	0	3.03314408470155	5.82597157350083	RB1;KAT2A
G-protein Beta Gamma Signalling	1/32	0.14830402193397793	0.17800756523199368	0	0	6.474095796676441	12.355752978101908	BTK
Nuclear Signaling by ERBB4	1/32	0.14830402193397793	0.17800756523199368	0	0	6.474095796676441	12.355752978101908	SRC
Transcriptional Regulation of Pluripotent Stem Cells	1/32	0.14830402193397793	0.17800756523199368	0	0	6.474095796676441	12.355752978101908	STAT3
DNA Replication	2/143	0.1604167144707384	0.19226924194838144	0	0	2.859892893327544	5.233547895270227	CCNE1;SKP2
Activated PKN1 Stimulates Transcription of AR (Androgen Receptor) Regulated Genes KLK2 and KLK3	1/35	0.16103657577419495	0.19245834665696468	0	0	5.901960784313726	10.777710825180796	AR
Transcriptional Regulation by NPAS4	1/35	0.16103657577419495	0.19245834665696468	0	0	5.901960784313726	10.777710825180796	MAPK3
Nuclear Pore Complex (NPC) Disassembly	1/36	0.16523874056701404	0.1971975227683706	0	0	5.733044733044733	10.321566994169176	CDK1
FCERI Mediated NF-kB Activation	2/147	0.1674678305136682	0.19957182091256884	0	0	2.780436312456017	4.968539602428729	LYN;RELA
Apoptotic Cleavage of Cellular Proteins	1/38	0.17358065793162564	0.20626631677181761	0	0	5.422604422604422	9.495592558231127	PTK2
Triglyceride Metabolism	1/38	0.17358065793162564	0.20626631677181761	0	0	5.422604422604422	9.495592558231127	CAV1
Vesicle-mediated Transport	6/752	0.1745904932255626	0.20717077045141546	0	0	1.638868290456905	2.8603366345965724	HSP90AA1;SRC;KDELR2;GRB2;CBL;EGFR
Mitophagy	1/39	0.17772061456847035	0.20969018687752947	0	0	5.279638490164806	9.12080010262218	SRC
Ovarian Tumor Domain Proteases	1/39	0.17772061456847035	0.20969018687752947	0	0	5.279638490164806	9.12080010262218	CDK1
Response of Mtb to Phagocytosis	1/39	0.17772061456847035	0.20969018687752947	0	0	5.279638490164806	9.12080010262218	MAPK3
SUMOylation of Ubiquitinylation Proteins	1/39	0.17772061456847035	0.20969018687752947	0	0	5.279638490164806	9.12080010262218	VHL
Class C 3 (Metabotropic Glutamate Pheromone Receptors)	1/40	0.18184003844564067	0.2142471740102103	0	0	5.144004144004144	8.768612919919887	GRM1
DAG and IP3 Signaling	1/41	0.1859390303366049	0.21832933575740004	0	0	5.015151515151516	8.43717221072756	PLCG1
Sensory Perception of Sweet, Bitter, and Umami (Glutamate) Taste	1/41	0.1859390303366049	0.21832933575740004	0	0	5.015151515151516	8.43717221072756	GRM1
Organelle Biogenesis and Maintenance	3/297	0.18609103047749584	0.21832933575740004	0	0	2.0624868504102674	3.4681114734691603	HSP90AA1;CDK1;MAPK14
G Alpha (S) Signalling Events	2/158	0.18711815886392233	0.219225634787127	0	0	2.5829408686551543	4.329047629874819	SHC1;SRC
Formation of WDR5-containing Histone-Modifying Complexes	1/42	0.1900176905858975	0.22168730568354708	0	0	4.892584380389258	8.124812043283224	KAT2A
Regulation of MITF-M-dependent Genes Involved in Pigmentation	1/42	0.1900176905858975	0.22168730568354708	0	0	4.892584380389258	8.124812043283224	MAPK14
Regulation of Beta-Cell Development	1/42	0.1900176905858975	0.22168730568354708	0	0	4.892584380389258	8.124812043283224	KAT2A
Activation of Gene Expression by SREBF (SREBP)	1/43	0.19407611900781976	0.22578967476747744	0	0	4.775853775853776	7.830035336967146	SP1
Aggrephagy	1/43	0.19407611900781976	0.22578967476747744	0	0	4.775853775853776	7.830035336967146	HSP90AA1
Smooth Muscle Contraction	1/44	0.19811441496549978	0.229526158089376	0	0	4.664552501761804	7.551493311263548	PXN
Stabilization of P53	1/44	0.19811441496549978	0.229526158089376	0	0	4.664552501761804	7.551493311263548	MDM4
TP53 Regulates Transcription of Cell Death Genes	1/44	0.19811441496549978	0.229526158089376	0	0	4.664552501761804	7.551493311263548	TP73
Regulation of RUNX3 Expression and Activity	1/45	0.20213267727917436	0.23353192811865775	0	0	4.558310376492194	7.287967841732019	SRC
TAK1-dependent IKK and NF-kappa-B Activation	1/45	0.20213267727917436	0.23353192811865775	0	0	4.558310376492194	7.287967841732019	RELA
Interleukin-10 Signaling	1/46	0.20613100438312365	0.23716453957340056	0	0	4.45679012345679	7.038356248208516	STAT3
Interleukin-12 Signaling	1/46	0.20613100438312365	0.23716453957340056	0	0	4.45679012345679	7.038356248208516	JAK2
PKMTs Methylate Histone Lysines	1/46	0.20613100438312365	0.23716453957340056	0	0	4.45679012345679	7.038356248208516	RELA
Sensory Perception of Taste	1/47	0.2101094941683413	0.241395593810477	0	0	4.359683794466403	6.801658146757973	GRM1
Membrane Trafficking	5/633	0.21038799652629808	0.241395593810477	0	0	1.6151525310090513	2.5177027541388077	SRC;KDELR2;GRB2;CBL;EGFR
RMTs Methylate Histone Arginines	1/48	0.2140682440880332	0.24460747232555782	0	0	4.266709649688373	6.576964036635908	JAK2
RNA Polymerase I Transcription Initiation	1/48	0.2140682440880332	0.24460747232555782	0	0	4.266709649688373	6.576964036635908	KAT2A
Recycling Pathway of L1	1/48	0.2140682440880332	0.24460747232555782	0	0	4.266709649688373	6.576964036635908	SRC
XBP1(S) Activates Chaperone Genes	1/49	0.21800735103248006	0.24808760028696158	0	0	4.177609427609427	6.363445371866637	SHC1
Dectin-1 Mediated Noncanonical NF-kB Signaling	1/49	0.21800735103248006	0.24808760028696158	0	0	4.177609427609427	6.363445371866637	RELA
Signaling by TGFBR3	1/49	0.21800735103248006	0.24808760028696158	0	0	4.177609427609427	6.363445371866637	SP1
Regulation of TNFR1 Signaling	1/50	0.22192691156038513	0.25220343428349357	0	0	4.092145949288806	6.1603458876211565	STUB1
Gap Junction Trafficking and Regulation	1/51	0.22582702165646545	0.2555895503258638	0	0	4.01010101010101	5.966974015935645	SRC
IRE1alpha Activates Chaperones	1/51	0.22582702165646545	0.2555895503258638	0	0	4.01010101010101	5.966974015935645	SHC1
Transcriptional and Post-Translational Regulation of MITF-M Expression and Activity	1/51	0.22582702165646545	0.2555895503258638	0	0	4.01010101010101	5.966974015935645	MAPK3
Apoptotic Execution Phase	1/52	0.22970777681698884	0.2596290069044121	0	0	3.9312735195088138	5.782696221966044	PTK2
Nuclear Envelope Breakdown	1/53	0.23356927222454107	0.26327903080249354	0	0	3.8554778554778553	5.606931137649977	CDK1
Nuclear Receptor Transcription Pathway	1/53	0.23356927222454107	0.26327903080249354	0	0	3.8554778554778553	5.606931137649977	AR
Activation of NF-kappaB in B Cells	1/54	0.23741160244685378	0.2668878067992297	0	0	3.7825424051839147	5.43914439332398	RELA
SARS-CoV-1 Activates Modulates Innate Immune Responses	1/54	0.23741160244685378	0.2668878067992297	0	0	3.7825424051839147	5.43914439332398	RELA
Regulation of RAS by GAPs	1/55	0.2412348616553018	0.2708202692168011	0	0	3.7123082678638233	5.278844037828421	RASA1
TCF Dependent Signaling in Response to WNT	2/189	0.2438580650566493	0.273396727041977	0	0	2.1513696387645966	3.0359459772502695	MYC;CAV1
Regulation of Cholesterol Biosynthesis by SREBP (SREBF)	1/56	0.24503914356804327	0.27435162176368283	0	0	3.644628099173554	5.125576482532065	SP1
Neurexins and Neuroligins	1/57	0.24882454141300062	0.2782158966403081	0	0	3.5793650793650795	4.978922896997587	GRM1
Orc1 Removal From Chromatin	1/58	0.2525911479606718	0.28204882875501286	0	0	3.5163919900762006	4.8384959983786695	SKP2
B-WICH Complex Positively Regulates rRNA Expression	1/59	0.25633905564263204	0.2854684937838402	0	0	3.4555903866248694	4.703937185372145	KAT2A
TNF Signaling	1/59	0.25633905564263204	0.2854684937838402	0	0	3.4555903866248694	4.703937185372145	STUB1
CDK-mediated Phosphorylation and Removal of Cdc6	1/60	0.26006835626766184	0.2884646348481522	0	0	3.396849854476973	4.574913980988086	CCNE1
Cdc20 Phospho-APC C Mediated Degradation of Cyclin A	1/60	0.26006835626766184	0.2884646348481522	0	0	3.396849854476973	4.574913980988086	CDK1
Formation of the Beta-Catenin TCF Transactivating Complex	1/60	0.26006835626766184	0.2884646348481522	0	0	3.396849854476973	4.574913980988086	MYC
APC Cdc20 Mediated Degradation of Cell Cycle Proteins Prior to Satisfation of the Checkpoint	1/61	0.26377914130867525	0.29180348567081865	0	0	3.34006734006734	4.4511177340934625	CDK1
Regulation of PTEN Gene Transcription	1/61	0.26377914130867525	0.29180348567081865	0	0	3.34006734006734	4.4511177340934625	MAPK3
Cilium Assembly	2/200	0.2642273190435063	0.29191161374435115	0	0	2.0307153164296023	2.702771390555414	HSP90AA1;CDK1
RHO GTPases Activate PKNs	1/62	0.2674715018007107	0.29510431920528746	0	0	3.2851465474416295	4.3322615615299345	AR
Mitotic Prometaphase	2/203	0.2697872573969225	0.2972655891688313	0	0	2.000101533150574	2.6203761530404495	HSP90AA1;CDK1
APC C Cdc20 Mediated Degradation of Mitotic Proteins	1/63	0.2711455282609312	0.2979739116640576	0	0	3.231997393287716	4.218078497375417	CDK1
Ca2+ Pathway	1/63	0.2711455282609312	0.2979739116640576	0	0	3.231997393287716	4.218078497375417	MYC
Neurotransmitter Receptors and Postsynaptic Signal Transmission	2/204	0.2716405416203822	0.2981245996966777	0	0	1.99009900990099	2.5936475306384104	SRC;MAPK3
Activation of APC C and APC C Cdc20 Mediated Degradation of Mitotic Proteins	1/64	0.2748013108427819	0.3008009092405221	0	0	3.1805355138688474	4.108319823136149	CDK1
Cytosolic Sensors of Pathogen-Associated DNA	1/64	0.2748013108427819	0.3008009092405221	0	0	3.1805355138688474	4.108319823136149	RELA
Downstream Signaling Events of B Cell Receptor (BCR)	1/68	0.2892437892552286	0.3157799167098367	0	0	2.990049751243781	3.7091130169332227	RELA
Regulation of APC C Activators Between G1 S and Early Anaphase	1/68	0.2892437892552286	0.3157799167098367	0	0	2.990049751243781	3.7091130169332227	CDK1
Circadian Clock	1/70	0.29635787620352466	0.32312318177687965	0	0	2.9030888596105986	3.530700422312052	HIF1A
Degradation of Beta-Catenin by the Destruction Complex	1/72	0.30340146185965494	0.3299391876358911	0	0	2.821027173139849	3.3646345783285243	MYC
Signaling by NOTCH4	1/72	0.30340146185965494	0.3299391876358911	0	0	2.821027173139849	3.3646345783285243	KAT2A
Pre-NOTCH Transcription and Translation	1/73	0.30689703311188365	0.3333053827668828	0	0	2.781705948372615	3.2858706369655613	KAT2A
Nuclear Envelope (NE) Reassembly	1/75	0.31383616164844547	0.33995516599890124	0	0	2.7062517062517064	3.1362323637249645	CDK1
Positive Epigenetic Regulation of rRNA Expression	1/75	0.31383616164844547	0.33995516599890124	0	0	2.7062517062517064	3.1362323637249645	KAT2A
Regulation of mRNA Stability by Proteins That Bind AU-rich Elements	1/76	0.31727988935066437	0.3432391530248096	0	0	2.67003367003367	3.0651211233087037	MAPK14
G2 M DNA Damage Checkpoint	1/77	0.3207065055587057	0.3464961337618701	0	0	2.6347687400318978	2.996335121708695	CDK1
Metabolism of Lipids	5/758	0.32926753322803326	0.3552847865012328	0	0	1.3382959390508142	1.4866924663765475	SP1;CAV1;PIK3R3;PIK3R2;PIK3R1
ER-Phagosome Pathway	1/80	0.3308845249727721	0.35656767050752797	0	0	2.534330648254699	2.8029337896230073	BTK
RNA Polymerase II Transcribes snRNA Genes	1/81	0.33424353285435243	0.35972204504867644	0	0	2.5025252525252526	2.742480915944007	SP1
Infection With Mycobacterium Tuberculosis	1/82	0.3375858460637784	0.36285033518855153	0	0	2.471505175208879	2.6838950656014107	MAPK3
Neuronal System	3/411	0.33837475064059924	0.36322959701497315	0	0	1.4775621588841723	1.6010882288862256	SRC;GRM1;MAPK3
Transcriptional Regulation of White Adipocyte Differentiation	1/84	0.34422071652682057	0.3690294168170418	0	0	2.4117074358038213	2.572018957842433	RELA
Integrin Cell Surface Interactions	1/85	0.34751343686607217	0.37160294340107586	0	0	2.382876382876383	2.5185858334956643	CD44
RUNX1 Regulates Transcription of Genes Involved in Differentiation of HSCs	1/85	0.34751343686607217	0.37160294340107586	0	0	2.382876382876383	2.5185858334956643	TP73
Protein-protein Interactions at Synapses	1/88	0.35729370848339814	0.381571357905988	0	0	2.3003599210495764	2.367523811703655	GRM1
Pre-NOTCH Expression and Processing	1/89	0.3605214364245345	0.38452542450913857	0	0	2.2741046831955924	2.32005037808893	KAT2A
Unfolded Protein Response (UPR)	1/95	0.37955353321698265	0.4043070245137424	0	0	2.1283043197936813	2.061815304518316	SHC1
Antigen processing-Cross Presentation	1/96	0.38267056588073545	0.40710674505575045	0	0	2.105794790005316	2.022786046627892	BTK
Mitochondrial Biogenesis	1/97	0.38577209484285213	0.4098828507705304	0	0	2.083754208754209	1.9847936202473102	MAPK14
Transmission Across Chemical Synapses	2/269	0.39014369858340703	0.41399961900634147	0	0	1.5006496980814799	1.412471746643874	SRC;MAPK3
COPI-dependent Golgi-to-ER Retrograde Traffic	1/101	0.3980246944821334	0.42128916201222	0	0	2.0	1.8424824583699577	KDELR2
COPI-mediated Anterograde Transport	1/101	0.3980246944821334	0.42128916201222	0	0	2.0	1.8424824583699577	KDELR2
Epigenetic Regulation of Adipogenesis Genes by MLL3 and MLL4 Complexes	1/103	0.4040599390731852	0.4260530749974219	0	0	1.9605862547039017	1.776667673398047	RB1
Epigenetic Regulation of Gene Expression by MLL3 and MLL4 Complexes	1/103	0.4040599390731852	0.4260530749974219	0	0	1.9605862547039017	1.776667673398047	RB1
MLL4 and MLL3 Complexes Regulate Expression of PPARG Targets in Adipogenesis and Hepatic Steatosis	1/103	0.4040599390731852	0.4260530749974219	0	0	1.9605862547039017	1.776667673398047	RB1
Phase I - Functionalization of Compounds	1/105	0.41003527484740526	0.43180705935257724	0	0	1.9226884226884227	1.7140999679223647	HSP90AB1
HATs Acetylate Histones	1/108	0.41888723576300985	0.4405720547860949	0	0	1.8684980647597471	1.6258801725332535	KAT2A
Signaling by WNT	2/287	0.42162443378718406	0.4425271260618275	0	0	1.4045828857858933	1.2130544249293134	MYC;CAV1
RSV-host Interactions	1/109	0.42180856913936493	0.4425271260618275	0	0	1.8511036288814067	1.5978794932003777	BECN1
Adipogenesis	1/110	0.4247153626139249	0.44501622271371	0	0	1.8340283569641367	1.570544634474372	RELA
Epigenetic Regulation of Gene Expression	2/291	0.428510552832088	0.44842875692101675	0	0	1.3848598262834546	1.1735854919050652	RB1;KAT2A
PPARA Activates Gene Expression	1/117	0.4446617754820939	0.46474687450010566	0	0	1.7227446882619297	1.396183515184437	SP1
Regulation of Lipid Metabolism by PPARalpha	1/119	0.45023391713708705	0.4699810187659066	0	0	1.6933744221879816	1.3512924945163796	SP1
Binding and Uptake of Ligands by Scavenger Receptors	1/122	0.45848850701645666	0.4779986562511995	0	0	1.6511394941147006	1.2875916896026691	HSP90AA1
Resolution of Sister Chromatid Cohesion	1/126	0.46930404232413414	0.48866283407000466	0	0	1.597979797979798	1.2088788165174762	CDK1
Glycosaminoglycan Metabolism	1/127	0.47197433920713694	0.49082974352003134	0	0	1.5852172518839185	1.1902297169988543	CD44
Platelet Degranulation	1/128	0.47463133363816096	0.4929774325693118	0	0	1.572655690765927	1.171969623816576	HGF
Formation of the Cornified Envelope	1/129	0.47727509120180356	0.4951060410599033	0	0	1.560290404040404	1.1540879003160078	JUP
Response to Elevated Platelet Cytosolic Ca2+	1/133	0.487719053875974	0.5053109102968735	0	0	1.512702785430058	1.0861444222602046	HGF
Beta-catenin Independent WNT Signaling	1/134	0.4902976000706425	0.5067219613633315	0	0	1.5012531328320802	1.0700072490423937	MYC
Gene Silencing by RNA	1/134	0.4902976000706425	0.5067219613633315	0	0	1.5012531328320802	1.0700072490423937	HSP90AA1
Golgi-to-ER Retrograde Transport	1/135	0.4928632963661163	0.5087424112428437	0	0	1.4899743705713855	1.0541917813157848	KDELR2
G2 M Checkpoints	1/137	0.49795639252529783	0.5133634591257092	0	0	1.467914438502674	1.0234927306951356	CDK1
RHO GTPases Activate Formins	1/139	0.502998845735877	0.5179209375747659	0	0	1.4464939247547943	0.993983474661611	SRC
Degradation of the Extracellular Matrix	1/140	0.5055012372413341	0.5198549760765818	0	0	1.4360148245040332	0.9796561960455777	CD44
Influenza Viral RNA Transcription and Replication	1/149	0.5274687471502818	0.5417773938054066	0	0	1.348075348075348	0.8623175106205572	HSP90AA1
ER to Golgi Anterograde Transport	1/155	0.5415741406288901	0.5548969977169317	0	0	1.295159386068477	0.7942892672270463	KDELR2
Metabolism of Steroids	1/155	0.5415741406288901	0.5548969977169317	0	0	1.295159386068477	0.7942892672270463	SP1
Factors Involved in Megakaryocyte Development and Platelet Production	1/158	0.5484697017864213	0.5612718201327873	0	0	1.270218104613009	0.7629225123606185	JAK2
Influenza Infection	1/169	0.5728862133976284	0.5855389150432202	0	0	1.1863876863876863	0.6608988084033616	HSP90AA1
Transport to the Golgi and Subsequent Modification	1/186	0.6080733489730797	0.6207415437433522	0	0	1.0764400764400763	0.5354856269608474	KDELR2
Metabolism of Vitamins and Cofactors	1/198	0.6311679368829785	0.6435286308733428	0	0	1.010254832589858	0.4649024106032371	HSP90AA1
Intra-Golgi and Retrograde Golgi-to-ER Traffic	1/204	0.6422047284719372	0.6531825870782951	0	0	0.9800965318206698	0.4340339206746572	KDELR2
Muscle Contraction	1/204	0.6422047284719372	0.6531825870782951	0	0	0.9800965318206698	0.4340339206746572	PXN
HCMV Early Events	1/205	0.6440121337651465	0.654222082227277	0	0	0.9752426223014459	0.4291435319722849	EGFR
Metabolism	10/2181	0.6618623300530478	0.6715363226969413	0	0	0.9073647576641589	0.3744673533734098	HSP90AA1;HSP90AB1;SP1;CAV1;PLCG2;PIK3R3;PIK3R2;PIK3R1;PLCG1;CD44
Keratinization	1/217	0.6650085743924802	0.6739077158989488	0	0	0.9205013093901983	0.3755234288642614	JUP
Mitotic Anaphase	1/221	0.6717311879104819	0.6798931707526507	0	0	0.9035812672176309	0.35953230844282336	CDK1
Biological Oxidations	1/222	0.6733908646234461	0.6799207154319159	0	0	0.8994469582704877	0.3556677156302322	HSP90AB1
Mitotic Metaphase and Anaphase	1/222	0.6733908646234461	0.6799207154319159	0	0	0.8994469582704877	0.3556677156302322	CDK1
HCMV Infection	1/259	0.7292914958406512	0.7354719322460804	0	0	0.7690079085427922	0.24276177753960482	EGFR
Metabolism of RNA	3/761	0.7382599928860916	0.7436161717945758	0	0	0.781029839784566	0.23701070796077725	MYC;MAPK14;CD44
Metabolism of Carbohydrates	1/290	0.7687519774127153	0.7733941994985408	0	0	0.6854356715948412	0.18026059393681856	CD44
Extracellular Matrix Organization	1/300	0.7802227102911928	0.7839873554554446	0	0	0.6621735752170534	0.16433550579498515	CD44
Asparagine N-linked Glycosylation	1/306	0.7868328435807778	0.7896768177142023	0	0	0.6489485014075178	0.15557855687003125	KDELR2
G Alpha (I) Signalling Events	1/316	0.7974150897750656	0.799334259666221	0	0	0.6280262946929613	0.14217254266011148	SRC
GPCR Ligand Binding	1/467	0.9063896808132167	0.9074790914872711	0	0	0.4212511379893354	0.041403070028844594	GRM1
Sensory Perception	1/640	0.9616300594869738	0.9616300594869738	0	0	0.30446878803686317	0.011912480116108504	GRM1
